Spaces:
Running
Running
Sami
commited on
Commit
·
5269745
1
Parent(s):
444791c
works
Browse files- .history/index_20250131185409.html +405 -0
- .history/index_20250131185615.html +531 -0
- .history/index_20250131185947.html +588 -0
- .history/index_20250131185948.html +588 -0
- index.html +196 -13
.history/index_20250131185409.html
ADDED
@@ -0,0 +1,405 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html>
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<title>Glaucoma: A Comprehensive Overview</title>
|
5 |
+
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
6 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.css">
|
7 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/theme/white.min.css">
|
8 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
|
9 |
+
<style>
|
10 |
+
:root {
|
11 |
+
--r-main-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
12 |
+
--r-heading-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
13 |
+
--r-main-color: #2d3436;
|
14 |
+
--r-heading-color: #0984e3;
|
15 |
+
}
|
16 |
+
|
17 |
+
.reveal .slides {
|
18 |
+
text-align: left;
|
19 |
+
font-family: var(--r-main-font);
|
20 |
+
}
|
21 |
+
|
22 |
+
.reveal .slides section {
|
23 |
+
padding: 40px;
|
24 |
+
transition: transform 0.8s cubic-bezier(0.4, 0, 0.2, 1),
|
25 |
+
opacity 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
26 |
+
}
|
27 |
+
|
28 |
+
.reveal h1, .reveal h2 {
|
29 |
+
color: var(--r-heading-color);
|
30 |
+
font-weight: 600;
|
31 |
+
letter-spacing: -0.02em;
|
32 |
+
margin-bottom: 1em;
|
33 |
+
}
|
34 |
+
|
35 |
+
.reveal p, .reveal li {
|
36 |
+
font-size: 1.1em;
|
37 |
+
line-height: 1.6;
|
38 |
+
color: var(--r-main-color);
|
39 |
+
}
|
40 |
+
|
41 |
+
.reveal ul, .reveal ol {
|
42 |
+
background: #f8f9fa;
|
43 |
+
border-radius: 8px;
|
44 |
+
padding: 20px 40px;
|
45 |
+
box-shadow: 0 2px 8px rgba(0,0,0,0.05);
|
46 |
+
}
|
47 |
+
|
48 |
+
.image-container {
|
49 |
+
background: white;
|
50 |
+
padding: 20px;
|
51 |
+
border-radius: 12px;
|
52 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
53 |
+
margin: 20px 0;
|
54 |
+
}
|
55 |
+
|
56 |
+
.image-container img {
|
57 |
+
max-width: 100%;
|
58 |
+
border-radius: 8px;
|
59 |
+
display: block;
|
60 |
+
margin: 0 auto;
|
61 |
+
}
|
62 |
+
|
63 |
+
.image-caption {
|
64 |
+
text-align: center;
|
65 |
+
color: #636e72;
|
66 |
+
font-size: 0.8em;
|
67 |
+
margin-top: 10px;
|
68 |
+
}
|
69 |
+
|
70 |
+
/* Navigation buttons styling */
|
71 |
+
.reveal .controls {
|
72 |
+
color: var(--r-heading-color);
|
73 |
+
}
|
74 |
+
|
75 |
+
.reveal .controls button {
|
76 |
+
padding: 12px;
|
77 |
+
background: rgba(255, 255, 255, 0.9);
|
78 |
+
border-radius: 50%;
|
79 |
+
transition: all 0.3s ease;
|
80 |
+
box-shadow: 0 2px 6px rgba(0,0,0,0.1);
|
81 |
+
}
|
82 |
+
|
83 |
+
.reveal .controls button:hover {
|
84 |
+
background: var(--r-heading-color);
|
85 |
+
color: white;
|
86 |
+
transform: scale(1.1);
|
87 |
+
}
|
88 |
+
|
89 |
+
/* Progress bar enhancement */
|
90 |
+
.reveal .progress {
|
91 |
+
height: 4px;
|
92 |
+
background: rgba(9, 132, 227, 0.2);
|
93 |
+
}
|
94 |
+
|
95 |
+
.reveal .progress span {
|
96 |
+
background: var(--r-heading-color);
|
97 |
+
transition: width 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
98 |
+
}
|
99 |
+
|
100 |
+
/* Enhanced image handling */
|
101 |
+
.slide-image {
|
102 |
+
max-height: 50vh;
|
103 |
+
width: auto;
|
104 |
+
margin: 20px auto;
|
105 |
+
border-radius: 12px;
|
106 |
+
box-shadow: 0 4px 20px rgba(0,0,0,0.1);
|
107 |
+
transition: transform 0.3s ease;
|
108 |
+
}
|
109 |
+
|
110 |
+
.slide-image:hover {
|
111 |
+
transform: scale(1.02);
|
112 |
+
}
|
113 |
+
|
114 |
+
/* Two-column layout */
|
115 |
+
.columns {
|
116 |
+
display: flex;
|
117 |
+
justify-content: space-between;
|
118 |
+
gap: 40px;
|
119 |
+
margin: 20px 0;
|
120 |
+
}
|
121 |
+
|
122 |
+
.column {
|
123 |
+
flex: 1;
|
124 |
+
}
|
125 |
+
|
126 |
+
/* Visual elements */
|
127 |
+
.highlight-box {
|
128 |
+
background: linear-gradient(135deg, rgba(9, 132, 227, 0.1), rgba(9, 132, 227, 0.05));
|
129 |
+
border-left: 4px solid var(--r-heading-color);
|
130 |
+
padding: 20px;
|
131 |
+
border-radius: 8px;
|
132 |
+
margin: 20px 0;
|
133 |
+
}
|
134 |
+
|
135 |
+
.icon-text {
|
136 |
+
display: flex;
|
137 |
+
align-items: center;
|
138 |
+
gap: 15px;
|
139 |
+
margin: 10px 0;
|
140 |
+
}
|
141 |
+
|
142 |
+
.icon-text i {
|
143 |
+
color: var(--r-heading-color);
|
144 |
+
font-size: 1.5em;
|
145 |
+
}
|
146 |
+
</style>
|
147 |
+
</head>
|
148 |
+
<body>
|
149 |
+
<div class="reveal">
|
150 |
+
<div class="slides">
|
151 |
+
|
152 |
+
<section>
|
153 |
+
<h1>Glaucoma: Understanding and Protecting Your Vision</h1>
|
154 |
+
<div class="columns">
|
155 |
+
<div class="column">
|
156 |
+
<p class="highlight-box">A comprehensive guide to understanding, preventing, and treating glaucoma</p>
|
157 |
+
<div class="icon-text">
|
158 |
+
<i class="fas fa-eye"></i>
|
159 |
+
<p>Leading cause of irreversible blindness worldwide</p>
|
160 |
+
</div>
|
161 |
+
<div class="icon-text">
|
162 |
+
<i class="fas fa-clock"></i>
|
163 |
+
<p>Early detection is crucial for prevention</p>
|
164 |
+
</div>
|
165 |
+
</div>
|
166 |
+
<div class="column">
|
167 |
+
|
168 |
+
</div>
|
169 |
+
</div>
|
170 |
+
</section>
|
171 |
+
|
172 |
+
<section>
|
173 |
+
<h2>What is Glaucoma?</h2>
|
174 |
+
<div class="columns">
|
175 |
+
<div class="column">
|
176 |
+
<div class="highlight-box">
|
177 |
+
<p>Glaucoma is a group of eye diseases that damage the optic nerve, often due to high intraocular pressure.</p>
|
178 |
+
</div>
|
179 |
+
<div class="icon-text">
|
180 |
+
<i class="fas fa-exclamation-triangle"></i>
|
181 |
+
<p>Often called the "silent thief of sight"</p>
|
182 |
+
</div>
|
183 |
+
</div>
|
184 |
+
<div class="column">
|
185 |
+
<img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?auto=format&fit=crop&w=800&q=80"
|
186 |
+
alt="Eye Close-up" class="slide-image">
|
187 |
+
</div>
|
188 |
+
</div>
|
189 |
+
</section>
|
190 |
+
|
191 |
+
<section>
|
192 |
+
<h2>Types of Glaucoma</h2>
|
193 |
+
<div class="columns">
|
194 |
+
<div class="column">
|
195 |
+
<ul>
|
196 |
+
<li><i class="fas fa-angle-right"></i> <strong>Open-Angle Glaucoma:</strong> Most common form</li>
|
197 |
+
<li><i class="fas fa-angle-right"></i> <strong>Angle-Closure Glaucoma:</strong> Medical emergency</li>
|
198 |
+
<li><i class="fas fa-angle-right"></i> <strong>Normal-Tension Glaucoma:</strong> Damage despite normal pressure</li>
|
199 |
+
</ul>
|
200 |
+
</div>
|
201 |
+
<div class="column">
|
202 |
+
<img src="https://images.unsplash.com/photo-1590486803833-1c5dc8ddd4c8?auto=format&fit=crop&w=800&q=80"
|
203 |
+
alt="Eye Diagram" class="slide-image">
|
204 |
+
</div>
|
205 |
+
</div>
|
206 |
+
</section>
|
207 |
+
|
208 |
+
<section data-background-gradient="linear-gradient(to bottom right, #ffffff, #f0f9ff)">
|
209 |
+
<h2>Risk Factors</h2>
|
210 |
+
<div class="columns">
|
211 |
+
<div class="column">
|
212 |
+
<div class="highlight-box">
|
213 |
+
<h3>Primary Risk Factors</h3>
|
214 |
+
<ul>
|
215 |
+
<li><i class="fas fa-user"></i> Age over 60</li>
|
216 |
+
<li><i class="fas fa-dna"></i> Family history</li>
|
217 |
+
<li><i class="fas fa-globe"></i> Ethnicity</li>
|
218 |
+
</ul>
|
219 |
+
</div>
|
220 |
+
</div>
|
221 |
+
<div class="column">
|
222 |
+
<div class="highlight-box">
|
223 |
+
<h3>Medical Risk Factors</h3>
|
224 |
+
<ul>
|
225 |
+
<li><i class="fas fa-heartbeat"></i> High blood pressure</li>
|
226 |
+
<li><i class="fas fa-prescription"></i> Diabetes</li>
|
227 |
+
<li><i class="fas fa-pills"></i> Long-term steroid use</li>
|
228 |
+
</ul>
|
229 |
+
</div>
|
230 |
+
</div>
|
231 |
+
</div>
|
232 |
+
</section>
|
233 |
+
|
234 |
+
<section>
|
235 |
+
<h2>Symptoms of Glaucoma</h2>
|
236 |
+
<p>Often, there are no early symptoms in open-angle glaucoma. Vision loss is slow and gradual. Angle-closure glaucoma can present with sudden symptoms.</p>
|
237 |
+
<ul>
|
238 |
+
<li><strong>Gradual peripheral vision loss (Open-angle)</strong></li>
|
239 |
+
<li><strong>Tunnel vision in advanced stages</strong></li>
|
240 |
+
<li><strong>Severe eye pain (Angle-closure)</strong></li>
|
241 |
+
<li><strong>Nausea and vomiting (Angle-closure)</strong></li>
|
242 |
+
<li><strong>Blurred vision</strong></li>
|
243 |
+
<li><strong>Halos around lights</strong></li>
|
244 |
+
<li><strong>Redness of the eye</strong></li>
|
245 |
+
</ul>
|
246 |
+
<img src="https://www.aao.org/asset.axd?id=48445490-a773-4181-889d-194a1989993b&t=637848477549500000" alt="Glaucoma Symptoms" style="max-height: 350px;">
|
247 |
+
<p style="font-size: 0.7em; color: #777;">Image source: aao.org</p>
|
248 |
+
</section>
|
249 |
+
|
250 |
+
<section>
|
251 |
+
<h2>Diagnosis</h2>
|
252 |
+
<p>Regular eye exams are crucial for early detection. Glaucoma can be diagnosed through various tests:</p>
|
253 |
+
<ol>
|
254 |
+
<li><strong>Tonometry:</strong> Measures intraocular pressure (IOP).</li>
|
255 |
+
<li><strong>Ophthalmoscopy:</strong> Examines the optic nerve for damage.</li>
|
256 |
+
<li><strong>Perimetry (Visual Field Test):</strong> Checks for peripheral vision loss.</li>
|
257 |
+
<li><strong>Gonioscopy:</strong> Inspects the drainage angle of the eye.</li>
|
258 |
+
<li><strong>Pachymetry:</strong> Measures corneal thickness.</li>
|
259 |
+
<li><strong>Optical Coherence Tomography (OCT):</strong> Imaging of the optic nerve and retina.</li>
|
260 |
+
</ol>
|
261 |
+
<img src="https://www.glaucoma.org/wp-content/uploads/2023/08/glaucoma-diagnosis-tests.jpg" alt="Glaucoma Diagnosis Tests" style="max-height: 300px;">
|
262 |
+
<p style="font-size: 0.7em; color: #777;">Image source: glaucoma.org</p>
|
263 |
+
</section>
|
264 |
+
|
265 |
+
<section>
|
266 |
+
<h2>Treatment: Eye Drops</h2>
|
267 |
+
<p>Medicated eye drops are the most common initial treatment. They help to lower eye pressure.</p>
|
268 |
+
<ul>
|
269 |
+
<li><strong>Prostaglandins:</strong> Increase fluid outflow.</li>
|
270 |
+
<li><strong>Beta-blockers:</strong> Reduce fluid production.</li>
|
271 |
+
<li><strong>Alpha-adrenergic agonists:</strong> Reduce fluid production and increase outflow.</li>
|
272 |
+
<li><strong>Carbonic anhydrase inhibitors:</strong> Reduce fluid production.</li>
|
273 |
+
<li><strong>Rho kinase inhibitors:</strong> Increase fluid outflow.</li>
|
274 |
+
</ul>
|
275 |
+
<img src="https://www.rxsafe.com/wp-content/uploads/2020/07/iStock-1142459298-1024x683.jpg" alt="Eye Drops for Glaucoma" style="max-height: 350px;">
|
276 |
+
<p style="font-size: 0.7em; color: #777;">Image source: rxsafe.com</p>
|
277 |
+
</section>
|
278 |
+
|
279 |
+
<section>
|
280 |
+
<h2>Treatment: Laser Therapy</h2>
|
281 |
+
<p>Laser procedures can help increase fluid drainage in the eye.</p>
|
282 |
+
<ul>
|
283 |
+
<li><strong>Trabeculoplasty (SLT/ALT):</strong> For open-angle glaucoma, to improve drainage.</li>
|
284 |
+
<li><strong>Iridotomy:</strong> For angle-closure glaucoma, to create a hole in the iris for fluid flow.</li>
|
285 |
+
<li><strong>Cyclophotocoagulation:</strong> To reduce fluid production in severe cases.</li>
|
286 |
+
</ul>
|
287 |
+
<img src="https://www.researchgate.net/publication/344019914/figure/fig1/AS:933628888879104@1599185878481/Selective-laser-trabeculoplasty-SLT-procedure-A-SLT-laser-delivery-system-B-SLT.png" alt="Laser Therapy for Glaucoma" style="max-height: 300px;">
|
288 |
+
<p style="font-size: 0.7em; color: #777;">Image source: researchgate.net</p>
|
289 |
+
</section>
|
290 |
+
|
291 |
+
<section>
|
292 |
+
<h2>Treatment: Surgery</h2>
|
293 |
+
<p>Surgical options are considered when eye drops and laser therapy are not sufficient.</p>
|
294 |
+
<ul>
|
295 |
+
<li><strong>Trabeculectomy:</strong> Creates a new drainage channel.</li>
|
296 |
+
<li><strong>Drainage Implants (Tube Shunts):</strong> Insert a tube to drain fluid.</li>
|
297 |
+
<li><strong>Minimally Invasive Glaucoma Surgery (MIGS):</strong> Less invasive procedures with faster recovery.</li>
|
298 |
+
</ul>
|
299 |
+
<img src="https://eyecareassociates.net/wp-content/uploads/2020/12/MIGS-surgery-options-for-glaucoma.png" alt="Glaucoma Surgery" style="max-height: 350px;">
|
300 |
+
<p style="font-size: 0.7em; color: #777;">Image source: eyecareassociates.net</p>
|
301 |
+
</section>
|
302 |
+
|
303 |
+
<section>
|
304 |
+
<h2>Living with Glaucoma</h2>
|
305 |
+
<p>Glaucoma is a chronic condition requiring ongoing management. Early detection and consistent treatment are key to preserving vision.</p>
|
306 |
+
<ul>
|
307 |
+
<li><strong>Regular eye exams are vital.</strong></li>
|
308 |
+
<li><strong>Adhere to prescribed treatments.</strong></li>
|
309 |
+
<li><strong>Maintain a healthy lifestyle.</strong></li>
|
310 |
+
<li><strong>Support groups and resources are available.</strong></li>
|
311 |
+
</ul>
|
312 |
+
<p><strong>Protect your vision. Get regular eye checks!</strong></p>
|
313 |
+
<img src="https://www.brightfocus.org/sites/default/files/styles/hero_image_1200x400/public/BrightFocus-Glaucoma-Hero-1200x400.jpg?itok=TsW_bDmz" alt="Living with Glaucoma" style="max-height: 300px;">
|
314 |
+
<p style="font-size: 0.7em; color: #777;">Image source: brightfocus.org</p>
|
315 |
+
</section>
|
316 |
+
|
317 |
+
</div>
|
318 |
+
</div>
|
319 |
+
|
320 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.js"></script>
|
321 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/zoom/zoom.min.js"></script>
|
322 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/notes/notes.min.js"></script>
|
323 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/search/search.min.js"></script>
|
324 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/markdown/markdown.min.js"></script>
|
325 |
+
|
326 |
+
<script>
|
327 |
+
Reveal.initialize({
|
328 |
+
// Modern configuration
|
329 |
+
hash: true,
|
330 |
+
mouseWheel: false,
|
331 |
+
transition: 'slide',
|
332 |
+
transitionSpeed: 'default',
|
333 |
+
backgroundTransition: 'fade',
|
334 |
+
autoPlayMedia: true,
|
335 |
+
|
336 |
+
// Enhanced animation settings
|
337 |
+
viewDistance: 3,
|
338 |
+
autoSlide: 0,
|
339 |
+
autoSlideStoppable: true,
|
340 |
+
|
341 |
+
// Improved navigation
|
342 |
+
controls: true,
|
343 |
+
controlsTutorial: true,
|
344 |
+
controlsLayout: 'bottom-right',
|
345 |
+
controlsBackArrows: 'faded',
|
346 |
+
progress: true,
|
347 |
+
center: true,
|
348 |
+
|
349 |
+
// Modern responsive design
|
350 |
+
width: 1200,
|
351 |
+
height: 700,
|
352 |
+
margin: 0.04,
|
353 |
+
minScale: 0.2,
|
354 |
+
maxScale: 2.0,
|
355 |
+
|
356 |
+
// Keyboard navigation
|
357 |
+
keyboard: {
|
358 |
+
13: 'next', // Enter
|
359 |
+
27: () => { }, // Escape (disable default ESC behavior)
|
360 |
+
32: 'next', // Space
|
361 |
+
37: 'prev', // Left arrow
|
362 |
+
38: 'prev', // Up arrow
|
363 |
+
39: 'next', // Right arrow
|
364 |
+
40: 'next' // Down arrow
|
365 |
+
},
|
366 |
+
|
367 |
+
// Plugins
|
368 |
+
plugins: [ RevealZoom, RevealNotes, RevealSearch, RevealMarkdown ],
|
369 |
+
|
370 |
+
// Progress bar styling
|
371 |
+
progress: {
|
372 |
+
color: '#0984e3',
|
373 |
+
height: '4px'
|
374 |
+
}
|
375 |
+
});
|
376 |
+
|
377 |
+
// Add keyboard shortcut for overview mode
|
378 |
+
document.addEventListener('keydown', function(event) {
|
379 |
+
if (event.key === 'o') {
|
380 |
+
Reveal.toggleOverview();
|
381 |
+
}
|
382 |
+
});
|
383 |
+
|
384 |
+
// Add smooth scroll behavior
|
385 |
+
Reveal.configure({
|
386 |
+
slideNumber: 'c/t',
|
387 |
+
touch: true,
|
388 |
+
hideInactiveCursor: true,
|
389 |
+
hideCursorTime: 3000
|
390 |
+
});
|
391 |
+
|
392 |
+
// Add animation on slide change
|
393 |
+
Reveal.on('slidechanged', event => {
|
394 |
+
const currentSlide = event.currentSlide;
|
395 |
+
const images = currentSlide.querySelectorAll('.slide-image');
|
396 |
+
images.forEach(img => {
|
397 |
+
img.style.opacity = 0;
|
398 |
+
setTimeout(() => {
|
399 |
+
img.style.opacity = 1;
|
400 |
+
}, 200);
|
401 |
+
});
|
402 |
+
});
|
403 |
+
</script>
|
404 |
+
</body>
|
405 |
+
</html>
|
.history/index_20250131185615.html
ADDED
@@ -0,0 +1,531 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html>
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<title>Glaucoma: A Comprehensive Overview</title>
|
5 |
+
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
6 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.css">
|
7 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/theme/white.min.css">
|
8 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
|
9 |
+
<style>
|
10 |
+
:root {
|
11 |
+
--r-main-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
12 |
+
--r-heading-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
13 |
+
--r-main-color: #2d3436;
|
14 |
+
--r-heading-color: #0984e3;
|
15 |
+
}
|
16 |
+
|
17 |
+
.reveal .slides {
|
18 |
+
text-align: left;
|
19 |
+
font-family: var(--r-main-font);
|
20 |
+
}
|
21 |
+
|
22 |
+
.reveal .slides section {
|
23 |
+
padding: 40px;
|
24 |
+
transition: transform 0.8s cubic-bezier(0.4, 0, 0.2, 1),
|
25 |
+
opacity 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
26 |
+
}
|
27 |
+
|
28 |
+
.reveal h1, .reveal h2 {
|
29 |
+
color: var(--r-heading-color);
|
30 |
+
font-weight: 600;
|
31 |
+
letter-spacing: -0.02em;
|
32 |
+
margin-bottom: 1em;
|
33 |
+
}
|
34 |
+
|
35 |
+
.reveal p, .reveal li {
|
36 |
+
font-size: 1.1em;
|
37 |
+
line-height: 1.6;
|
38 |
+
color: var(--r-main-color);
|
39 |
+
}
|
40 |
+
|
41 |
+
.reveal ul, .reveal ol {
|
42 |
+
background: #f8f9fa;
|
43 |
+
border-radius: 8px;
|
44 |
+
padding: 20px 40px;
|
45 |
+
box-shadow: 0 2px 8px rgba(0,0,0,0.05);
|
46 |
+
}
|
47 |
+
|
48 |
+
.image-container {
|
49 |
+
background: white;
|
50 |
+
padding: 20px;
|
51 |
+
border-radius: 12px;
|
52 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
53 |
+
margin: 20px 0;
|
54 |
+
}
|
55 |
+
|
56 |
+
.image-container img {
|
57 |
+
max-width: 100%;
|
58 |
+
border-radius: 8px;
|
59 |
+
display: block;
|
60 |
+
margin: 0 auto;
|
61 |
+
}
|
62 |
+
|
63 |
+
.image-caption {
|
64 |
+
text-align: center;
|
65 |
+
color: #636e72;
|
66 |
+
font-size: 0.8em;
|
67 |
+
margin-top: 10px;
|
68 |
+
}
|
69 |
+
|
70 |
+
/* Navigation buttons styling */
|
71 |
+
.reveal .controls {
|
72 |
+
color: var(--r-heading-color);
|
73 |
+
}
|
74 |
+
|
75 |
+
.reveal .controls button {
|
76 |
+
padding: 12px;
|
77 |
+
background: rgba(255, 255, 255, 0.9);
|
78 |
+
border-radius: 50%;
|
79 |
+
transition: all 0.3s ease;
|
80 |
+
box-shadow: 0 2px 6px rgba(0,0,0,0.1);
|
81 |
+
}
|
82 |
+
|
83 |
+
.reveal .controls button:hover {
|
84 |
+
background: var(--r-heading-color);
|
85 |
+
color: white;
|
86 |
+
transform: scale(1.1);
|
87 |
+
}
|
88 |
+
|
89 |
+
/* Progress bar enhancement */
|
90 |
+
.reveal .progress {
|
91 |
+
height: 4px;
|
92 |
+
background: rgba(9, 132, 227, 0.2);
|
93 |
+
}
|
94 |
+
|
95 |
+
.reveal .progress span {
|
96 |
+
background: var(--r-heading-color);
|
97 |
+
transition: width 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
98 |
+
}
|
99 |
+
|
100 |
+
/* Enhanced image handling */
|
101 |
+
.slide-image {
|
102 |
+
max-height: 50vh;
|
103 |
+
width: auto;
|
104 |
+
margin: 20px auto;
|
105 |
+
border-radius: 12px;
|
106 |
+
box-shadow: 0 4px 20px rgba(0,0,0,0.1);
|
107 |
+
transition: transform 0.3s ease;
|
108 |
+
}
|
109 |
+
|
110 |
+
.slide-image:hover {
|
111 |
+
transform: scale(1.02);
|
112 |
+
}
|
113 |
+
|
114 |
+
/* Two-column layout */
|
115 |
+
.columns {
|
116 |
+
display: flex;
|
117 |
+
justify-content: space-between;
|
118 |
+
gap: 40px;
|
119 |
+
margin: 20px 0;
|
120 |
+
}
|
121 |
+
|
122 |
+
.column {
|
123 |
+
flex: 1;
|
124 |
+
}
|
125 |
+
|
126 |
+
/* Visual elements */
|
127 |
+
.highlight-box {
|
128 |
+
background: linear-gradient(135deg, rgba(9, 132, 227, 0.1), rgba(9, 132, 227, 0.05));
|
129 |
+
border-left: 4px solid var(--r-heading-color);
|
130 |
+
padding: 20px;
|
131 |
+
border-radius: 8px;
|
132 |
+
margin: 20px 0;
|
133 |
+
}
|
134 |
+
|
135 |
+
.icon-text {
|
136 |
+
display: flex;
|
137 |
+
align-items: center;
|
138 |
+
gap: 15px;
|
139 |
+
margin: 10px 0;
|
140 |
+
}
|
141 |
+
|
142 |
+
.icon-text i {
|
143 |
+
color: var(--r-heading-color);
|
144 |
+
font-size: 1.5em;
|
145 |
+
}
|
146 |
+
|
147 |
+
.stats-grid {
|
148 |
+
display: grid;
|
149 |
+
grid-template-columns: repeat(2, 1fr);
|
150 |
+
gap: 20px;
|
151 |
+
margin-top: 20px;
|
152 |
+
}
|
153 |
+
|
154 |
+
.stat-item {
|
155 |
+
text-align: center;
|
156 |
+
padding: 15px;
|
157 |
+
background: rgba(255, 255, 255, 0.9);
|
158 |
+
border-radius: 8px;
|
159 |
+
}
|
160 |
+
|
161 |
+
.stat-number {
|
162 |
+
display: block;
|
163 |
+
font-size: 2em;
|
164 |
+
font-weight: bold;
|
165 |
+
color: var(--r-heading-color);
|
166 |
+
}
|
167 |
+
|
168 |
+
.stat-label {
|
169 |
+
font-size: 0.9em;
|
170 |
+
color: #666;
|
171 |
+
}
|
172 |
+
|
173 |
+
.chart-container {
|
174 |
+
background: white;
|
175 |
+
padding: 20px;
|
176 |
+
border-radius: 12px;
|
177 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
178 |
+
}
|
179 |
+
|
180 |
+
.chart-caption {
|
181 |
+
text-align: center;
|
182 |
+
font-size: 0.9em;
|
183 |
+
color: #666;
|
184 |
+
margin-top: 10px;
|
185 |
+
}
|
186 |
+
|
187 |
+
.interactive-eye {
|
188 |
+
position: relative;
|
189 |
+
}
|
190 |
+
|
191 |
+
.eye-hotspots .hotspot {
|
192 |
+
position: absolute;
|
193 |
+
width: 20px;
|
194 |
+
height: 20px;
|
195 |
+
background: rgba(9, 132, 227, 0.5);
|
196 |
+
border-radius: 50%;
|
197 |
+
cursor: pointer;
|
198 |
+
transition: all 0.3s ease;
|
199 |
+
}
|
200 |
+
|
201 |
+
.eye-hotspots .hotspot:hover {
|
202 |
+
background: rgba(9, 132, 227, 0.8);
|
203 |
+
transform: scale(1.2);
|
204 |
+
}
|
205 |
+
|
206 |
+
.eye-hotspots .hotspot:hover::after {
|
207 |
+
content: attr(data-tooltip);
|
208 |
+
position: absolute;
|
209 |
+
bottom: 100%;
|
210 |
+
left: 50%;
|
211 |
+
transform: translateX(-50%);
|
212 |
+
background: rgba(0, 0, 0, 0.8);
|
213 |
+
color: white;
|
214 |
+
padding: 5px 10px;
|
215 |
+
border-radius: 4px;
|
216 |
+
font-size: 0.8em;
|
217 |
+
white-space: nowrap;
|
218 |
+
}
|
219 |
+
</style>
|
220 |
+
</head>
|
221 |
+
<body>
|
222 |
+
<div class="reveal">
|
223 |
+
<div class="slides">
|
224 |
+
|
225 |
+
<section>
|
226 |
+
<h1>Glaucoma: Understanding and Protecting Your Vision</h1>
|
227 |
+
<div class="columns">
|
228 |
+
<div class="column">
|
229 |
+
<p class="highlight-box">A comprehensive guide to understanding, preventing, and treating glaucoma</p>
|
230 |
+
<div class="icon-text">
|
231 |
+
<i class="fas fa-eye"></i>
|
232 |
+
<p>Leading cause of irreversible blindness worldwide</p>
|
233 |
+
</div>
|
234 |
+
<div class="icon-text">
|
235 |
+
<i class="fas fa-clock"></i>
|
236 |
+
<p>Early detection is crucial for prevention</p>
|
237 |
+
</div>
|
238 |
+
<div class="icon-text">
|
239 |
+
<i class="fas fa-chart-line"></i>
|
240 |
+
<p>Affects over 80 million people globally</p>
|
241 |
+
</div>
|
242 |
+
</div>
|
243 |
+
<div class="column">
|
244 |
+
<div class="chart-container">
|
245 |
+
<canvas id="globalPrevalenceChart"></canvas>
|
246 |
+
<p class="chart-caption">Global Glaucoma Prevalence by Region (2020)</p>
|
247 |
+
</div>
|
248 |
+
</div>
|
249 |
+
</div>
|
250 |
+
</section>
|
251 |
+
|
252 |
+
<section>
|
253 |
+
<h2>What is Glaucoma?</h2>
|
254 |
+
<div class="columns">
|
255 |
+
<div class="column">
|
256 |
+
<div class="highlight-box">
|
257 |
+
<p>Glaucoma is a group of eye diseases that damage the optic nerve, often due to high intraocular pressure.</p>
|
258 |
+
<div class="stats-grid">
|
259 |
+
<div class="stat-item">
|
260 |
+
<span class="stat-number">50%</span>
|
261 |
+
<span class="stat-label">of cases are undiagnosed</span>
|
262 |
+
</div>
|
263 |
+
<div class="stat-item">
|
264 |
+
<span class="stat-number">2040</span>
|
265 |
+
<span class="stat-label">111.8M projected cases</span>
|
266 |
+
</div>
|
267 |
+
</div>
|
268 |
+
</div>
|
269 |
+
<div class="icon-text">
|
270 |
+
<i class="fas fa-exclamation-triangle"></i>
|
271 |
+
<p>Often called the "silent thief of sight"</p>
|
272 |
+
</div>
|
273 |
+
</div>
|
274 |
+
<div class="column">
|
275 |
+
<div class="interactive-eye">
|
276 |
+
<img src="https://www.nei.nih.gov/sites/default/files/2019-06/eye-anatomy_1.jpg"
|
277 |
+
alt="Eye Anatomy" class="slide-image">
|
278 |
+
<div class="eye-hotspots">
|
279 |
+
<div class="hotspot" style="top: 40%; left: 30%;" data-tooltip="Optic Nerve"></div>
|
280 |
+
<div class="hotspot" style="top: 35%; left: 60%;" data-tooltip="Trabecular Meshwork"></div>
|
281 |
+
<div class="hotspot" style="top: 45%; left: 45%;" data-tooltip="Anterior Chamber"></div>
|
282 |
+
</div>
|
283 |
+
</div>
|
284 |
+
</div>
|
285 |
+
</div>
|
286 |
+
</section>
|
287 |
+
|
288 |
+
<section>
|
289 |
+
<h2>Types of Glaucoma</h2>
|
290 |
+
<div class="columns">
|
291 |
+
<div class="column">
|
292 |
+
<ul>
|
293 |
+
<li><i class="fas fa-angle-right"></i> <strong>Open-Angle Glaucoma:</strong> Most common form</li>
|
294 |
+
<li><i class="fas fa-angle-right"></i> <strong>Angle-Closure Glaucoma:</strong> Medical emergency</li>
|
295 |
+
<li><i class="fas fa-angle-right"></i> <strong>Normal-Tension Glaucoma:</strong> Damage despite normal pressure</li>
|
296 |
+
</ul>
|
297 |
+
</div>
|
298 |
+
<div class="column">
|
299 |
+
<img src="https://images.unsplash.com/photo-1590486803833-1c5dc8ddd4c8?auto=format&fit=crop&w=800&q=80"
|
300 |
+
alt="Eye Diagram" class="slide-image">
|
301 |
+
</div>
|
302 |
+
</div>
|
303 |
+
</section>
|
304 |
+
|
305 |
+
<section data-background-gradient="linear-gradient(to bottom right, #ffffff, #f0f9ff)">
|
306 |
+
<h2>Risk Factors</h2>
|
307 |
+
<div class="columns">
|
308 |
+
<div class="column">
|
309 |
+
<div class="highlight-box">
|
310 |
+
<h3>Primary Risk Factors</h3>
|
311 |
+
<ul>
|
312 |
+
<li><i class="fas fa-user"></i> Age over 60</li>
|
313 |
+
<li><i class="fas fa-dna"></i> Family history</li>
|
314 |
+
<li><i class="fas fa-globe"></i> Ethnicity</li>
|
315 |
+
</ul>
|
316 |
+
</div>
|
317 |
+
</div>
|
318 |
+
<div class="column">
|
319 |
+
<div class="highlight-box">
|
320 |
+
<h3>Medical Risk Factors</h3>
|
321 |
+
<ul>
|
322 |
+
<li><i class="fas fa-heartbeat"></i> High blood pressure</li>
|
323 |
+
<li><i class="fas fa-prescription"></i> Diabetes</li>
|
324 |
+
<li><i class="fas fa-pills"></i> Long-term steroid use</li>
|
325 |
+
</ul>
|
326 |
+
</div>
|
327 |
+
</div>
|
328 |
+
</div>
|
329 |
+
</section>
|
330 |
+
|
331 |
+
<section>
|
332 |
+
<h2>Symptoms of Glaucoma</h2>
|
333 |
+
<p>Often, there are no early symptoms in open-angle glaucoma. Vision loss is slow and gradual. Angle-closure glaucoma can present with sudden symptoms.</p>
|
334 |
+
<ul>
|
335 |
+
<li><strong>Gradual peripheral vision loss (Open-angle)</strong></li>
|
336 |
+
<li><strong>Tunnel vision in advanced stages</strong></li>
|
337 |
+
<li><strong>Severe eye pain (Angle-closure)</strong></li>
|
338 |
+
<li><strong>Nausea and vomiting (Angle-closure)</strong></li>
|
339 |
+
<li><strong>Blurred vision</strong></li>
|
340 |
+
<li><strong>Halos around lights</strong></li>
|
341 |
+
<li><strong>Redness of the eye</strong></li>
|
342 |
+
</ul>
|
343 |
+
<img src="https://www.aao.org/asset.axd?id=48445490-a773-4181-889d-194a1989993b&t=637848477549500000" alt="Glaucoma Symptoms" style="max-height: 350px;">
|
344 |
+
<p style="font-size: 0.7em; color: #777;">Image source: aao.org</p>
|
345 |
+
</section>
|
346 |
+
|
347 |
+
<section>
|
348 |
+
<h2>Diagnosis</h2>
|
349 |
+
<p>Regular eye exams are crucial for early detection. Glaucoma can be diagnosed through various tests:</p>
|
350 |
+
<ol>
|
351 |
+
<li><strong>Tonometry:</strong> Measures intraocular pressure (IOP).</li>
|
352 |
+
<li><strong>Ophthalmoscopy:</strong> Examines the optic nerve for damage.</li>
|
353 |
+
<li><strong>Perimetry (Visual Field Test):</strong> Checks for peripheral vision loss.</li>
|
354 |
+
<li><strong>Gonioscopy:</strong> Inspects the drainage angle of the eye.</li>
|
355 |
+
<li><strong>Pachymetry:</strong> Measures corneal thickness.</li>
|
356 |
+
<li><strong>Optical Coherence Tomography (OCT):</strong> Imaging of the optic nerve and retina.</li>
|
357 |
+
</ol>
|
358 |
+
<img src="https://www.glaucoma.org/wp-content/uploads/2023/08/glaucoma-diagnosis-tests.jpg" alt="Glaucoma Diagnosis Tests" style="max-height: 300px;">
|
359 |
+
<p style="font-size: 0.7em; color: #777;">Image source: glaucoma.org</p>
|
360 |
+
</section>
|
361 |
+
|
362 |
+
<section>
|
363 |
+
<h2>Treatment: Eye Drops</h2>
|
364 |
+
<p>Medicated eye drops are the most common initial treatment. They help to lower eye pressure.</p>
|
365 |
+
<ul>
|
366 |
+
<li><strong>Prostaglandins:</strong> Increase fluid outflow.</li>
|
367 |
+
<li><strong>Beta-blockers:</strong> Reduce fluid production.</li>
|
368 |
+
<li><strong>Alpha-adrenergic agonists:</strong> Reduce fluid production and increase outflow.</li>
|
369 |
+
<li><strong>Carbonic anhydrase inhibitors:</strong> Reduce fluid production.</li>
|
370 |
+
<li><strong>Rho kinase inhibitors:</strong> Increase fluid outflow.</li>
|
371 |
+
</ul>
|
372 |
+
<img src="https://www.rxsafe.com/wp-content/uploads/2020/07/iStock-1142459298-1024x683.jpg" alt="Eye Drops for Glaucoma" style="max-height: 350px;">
|
373 |
+
<p style="font-size: 0.7em; color: #777;">Image source: rxsafe.com</p>
|
374 |
+
</section>
|
375 |
+
|
376 |
+
<section>
|
377 |
+
<h2>Treatment: Laser Therapy</h2>
|
378 |
+
<p>Laser procedures can help increase fluid drainage in the eye.</p>
|
379 |
+
<ul>
|
380 |
+
<li><strong>Trabeculoplasty (SLT/ALT):</strong> For open-angle glaucoma, to improve drainage.</li>
|
381 |
+
<li><strong>Iridotomy:</strong> For angle-closure glaucoma, to create a hole in the iris for fluid flow.</li>
|
382 |
+
<li><strong>Cyclophotocoagulation:</strong> To reduce fluid production in severe cases.</li>
|
383 |
+
</ul>
|
384 |
+
<img src="https://www.researchgate.net/publication/344019914/figure/fig1/AS:933628888879104@1599185878481/Selective-laser-trabeculoplasty-SLT-procedure-A-SLT-laser-delivery-system-B-SLT.png" alt="Laser Therapy for Glaucoma" style="max-height: 300px;">
|
385 |
+
<p style="font-size: 0.7em; color: #777;">Image source: researchgate.net</p>
|
386 |
+
</section>
|
387 |
+
|
388 |
+
<section>
|
389 |
+
<h2>Treatment: Surgery</h2>
|
390 |
+
<p>Surgical options are considered when eye drops and laser therapy are not sufficient.</p>
|
391 |
+
<ul>
|
392 |
+
<li><strong>Trabeculectomy:</strong> Creates a new drainage channel.</li>
|
393 |
+
<li><strong>Drainage Implants (Tube Shunts):</strong> Insert a tube to drain fluid.</li>
|
394 |
+
<li><strong>Minimally Invasive Glaucoma Surgery (MIGS):</strong> Less invasive procedures with faster recovery.</li>
|
395 |
+
</ul>
|
396 |
+
<img src="https://eyecareassociates.net/wp-content/uploads/2020/12/MIGS-surgery-options-for-glaucoma.png" alt="Glaucoma Surgery" style="max-height: 350px;">
|
397 |
+
<p style="font-size: 0.7em; color: #777;">Image source: eyecareassociates.net</p>
|
398 |
+
</section>
|
399 |
+
|
400 |
+
<section>
|
401 |
+
<h2>Living with Glaucoma</h2>
|
402 |
+
<p>Glaucoma is a chronic condition requiring ongoing management. Early detection and consistent treatment are key to preserving vision.</p>
|
403 |
+
<ul>
|
404 |
+
<li><strong>Regular eye exams are vital.</strong></li>
|
405 |
+
<li><strong>Adhere to prescribed treatments.</strong></li>
|
406 |
+
<li><strong>Maintain a healthy lifestyle.</strong></li>
|
407 |
+
<li><strong>Support groups and resources are available.</strong></li>
|
408 |
+
</ul>
|
409 |
+
<p><strong>Protect your vision. Get regular eye checks!</strong></p>
|
410 |
+
<img src="https://www.brightfocus.org/sites/default/files/styles/hero_image_1200x400/public/BrightFocus-Glaucoma-Hero-1200x400.jpg?itok=TsW_bDmz" alt="Living with Glaucoma" style="max-height: 300px;">
|
411 |
+
<p style="font-size: 0.7em; color: #777;">Image source: brightfocus.org</p>
|
412 |
+
</section>
|
413 |
+
|
414 |
+
</div>
|
415 |
+
</div>
|
416 |
+
|
417 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.js"></script>
|
418 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/zoom/zoom.min.js"></script>
|
419 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/notes/notes.min.js"></script>
|
420 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/search/search.min.js"></script>
|
421 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/markdown/markdown.min.js"></script>
|
422 |
+
|
423 |
+
<script>
|
424 |
+
Reveal.initialize({
|
425 |
+
// Modern configuration
|
426 |
+
hash: true,
|
427 |
+
mouseWheel: false,
|
428 |
+
transition: 'slide',
|
429 |
+
transitionSpeed: 'default',
|
430 |
+
backgroundTransition: 'fade',
|
431 |
+
autoPlayMedia: true,
|
432 |
+
|
433 |
+
// Enhanced animation settings
|
434 |
+
viewDistance: 3,
|
435 |
+
autoSlide: 0,
|
436 |
+
autoSlideStoppable: true,
|
437 |
+
|
438 |
+
// Improved navigation
|
439 |
+
controls: true,
|
440 |
+
controlsTutorial: true,
|
441 |
+
controlsLayout: 'bottom-right',
|
442 |
+
controlsBackArrows: 'faded',
|
443 |
+
progress: true,
|
444 |
+
center: true,
|
445 |
+
|
446 |
+
// Modern responsive design
|
447 |
+
width: 1200,
|
448 |
+
height: 700,
|
449 |
+
margin: 0.04,
|
450 |
+
minScale: 0.2,
|
451 |
+
maxScale: 2.0,
|
452 |
+
|
453 |
+
// Keyboard navigation
|
454 |
+
keyboard: {
|
455 |
+
13: 'next', // Enter
|
456 |
+
27: () => { }, // Escape (disable default ESC behavior)
|
457 |
+
32: 'next', // Space
|
458 |
+
37: 'prev', // Left arrow
|
459 |
+
38: 'prev', // Up arrow
|
460 |
+
39: 'next', // Right arrow
|
461 |
+
40: 'next' // Down arrow
|
462 |
+
},
|
463 |
+
|
464 |
+
// Plugins
|
465 |
+
plugins: [ RevealZoom, RevealNotes, RevealSearch, RevealMarkdown ],
|
466 |
+
|
467 |
+
// Progress bar styling
|
468 |
+
progress: {
|
469 |
+
color: '#0984e3',
|
470 |
+
height: '4px'
|
471 |
+
}
|
472 |
+
});
|
473 |
+
|
474 |
+
// Add keyboard shortcut for overview mode
|
475 |
+
document.addEventListener('keydown', function(event) {
|
476 |
+
if (event.key === 'o') {
|
477 |
+
Reveal.toggleOverview();
|
478 |
+
}
|
479 |
+
});
|
480 |
+
|
481 |
+
// Add smooth scroll behavior
|
482 |
+
Reveal.configure({
|
483 |
+
slideNumber: 'c/t',
|
484 |
+
touch: true,
|
485 |
+
hideInactiveCursor: true,
|
486 |
+
hideCursorTime: 3000
|
487 |
+
});
|
488 |
+
|
489 |
+
// Add animation on slide change
|
490 |
+
Reveal.on('slidechanged', event => {
|
491 |
+
const currentSlide = event.currentSlide;
|
492 |
+
const images = currentSlide.querySelectorAll('.slide-image');
|
493 |
+
images.forEach(img => {
|
494 |
+
img.style.opacity = 0;
|
495 |
+
setTimeout(() => {
|
496 |
+
img.style.opacity = 1;
|
497 |
+
}, 200);
|
498 |
+
});
|
499 |
+
});
|
500 |
+
|
501 |
+
// Initialize charts
|
502 |
+
document.addEventListener('DOMContentLoaded', function() {
|
503 |
+
const ctx = document.getElementById('globalPrevalenceChart').getContext('2d');
|
504 |
+
new Chart(ctx, {
|
505 |
+
type: 'doughnut',
|
506 |
+
data: {
|
507 |
+
labels: ['Asia', 'Africa', 'Europe', 'Americas', 'Oceania'],
|
508 |
+
datasets: [{
|
509 |
+
data: [45, 20, 15, 15, 5],
|
510 |
+
backgroundColor: [
|
511 |
+
'#0984e3',
|
512 |
+
'#00b894',
|
513 |
+
'#6c5ce7',
|
514 |
+
'#fdcb6e',
|
515 |
+
'#e17055'
|
516 |
+
]
|
517 |
+
}]
|
518 |
+
},
|
519 |
+
options: {
|
520 |
+
responsive: true,
|
521 |
+
plugins: {
|
522 |
+
legend: {
|
523 |
+
position: 'bottom'
|
524 |
+
}
|
525 |
+
}
|
526 |
+
}
|
527 |
+
});
|
528 |
+
});
|
529 |
+
</script>
|
530 |
+
</body>
|
531 |
+
</html>
|
.history/index_20250131185947.html
ADDED
@@ -0,0 +1,588 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html>
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<title>Glaucoma: A Comprehensive Overview</title>
|
5 |
+
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
6 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.css">
|
7 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/theme/white.min.css">
|
8 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
|
9 |
+
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/chart.js@4.4.1/dist/chart.min.css">
|
10 |
+
<style>
|
11 |
+
:root {
|
12 |
+
--r-main-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
13 |
+
--r-heading-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
14 |
+
--r-main-color: #2d3436;
|
15 |
+
--r-heading-color: #0984e3;
|
16 |
+
}
|
17 |
+
|
18 |
+
.reveal .slides {
|
19 |
+
text-align: left;
|
20 |
+
font-family: var(--r-main-font);
|
21 |
+
}
|
22 |
+
|
23 |
+
.reveal .slides section {
|
24 |
+
width: 100%;
|
25 |
+
height: 100%;
|
26 |
+
padding: 40px;
|
27 |
+
box-sizing: border-box;
|
28 |
+
display: flex;
|
29 |
+
flex-direction: column;
|
30 |
+
justify-content: center;
|
31 |
+
transition: transform 0.8s cubic-bezier(0.4, 0, 0.2, 1),
|
32 |
+
opacity 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
33 |
+
}
|
34 |
+
|
35 |
+
.reveal h1, .reveal h2 {
|
36 |
+
color: var(--r-heading-color);
|
37 |
+
font-weight: 600;
|
38 |
+
letter-spacing: -0.02em;
|
39 |
+
margin-bottom: 1em;
|
40 |
+
}
|
41 |
+
|
42 |
+
.reveal p, .reveal li {
|
43 |
+
font-size: 1.1em;
|
44 |
+
line-height: 1.6;
|
45 |
+
color: var(--r-main-color);
|
46 |
+
}
|
47 |
+
|
48 |
+
.reveal ul, .reveal ol {
|
49 |
+
background: #f8f9fa;
|
50 |
+
border-radius: 8px;
|
51 |
+
padding: 20px 40px;
|
52 |
+
box-shadow: 0 2px 8px rgba(0,0,0,0.05);
|
53 |
+
}
|
54 |
+
|
55 |
+
.image-container {
|
56 |
+
background: white;
|
57 |
+
padding: 20px;
|
58 |
+
border-radius: 12px;
|
59 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
60 |
+
margin: 20px 0;
|
61 |
+
}
|
62 |
+
|
63 |
+
.image-container img {
|
64 |
+
max-width: 100%;
|
65 |
+
border-radius: 8px;
|
66 |
+
display: block;
|
67 |
+
margin: 0 auto;
|
68 |
+
}
|
69 |
+
|
70 |
+
.image-caption {
|
71 |
+
text-align: center;
|
72 |
+
color: #636e72;
|
73 |
+
font-size: 0.8em;
|
74 |
+
margin-top: 10px;
|
75 |
+
}
|
76 |
+
|
77 |
+
/* Navigation buttons styling */
|
78 |
+
.reveal .controls {
|
79 |
+
color: var(--r-heading-color);
|
80 |
+
}
|
81 |
+
|
82 |
+
.reveal .controls button {
|
83 |
+
padding: 12px;
|
84 |
+
background: rgba(255, 255, 255, 0.9);
|
85 |
+
border-radius: 50%;
|
86 |
+
transition: all 0.3s ease;
|
87 |
+
box-shadow: 0 2px 6px rgba(0,0,0,0.1);
|
88 |
+
}
|
89 |
+
|
90 |
+
.reveal .controls button:hover {
|
91 |
+
background: var(--r-heading-color);
|
92 |
+
color: white;
|
93 |
+
transform: scale(1.1);
|
94 |
+
}
|
95 |
+
|
96 |
+
/* Progress bar enhancement */
|
97 |
+
.reveal .progress {
|
98 |
+
height: 4px;
|
99 |
+
background: rgba(9, 132, 227, 0.2);
|
100 |
+
}
|
101 |
+
|
102 |
+
.reveal .progress span {
|
103 |
+
background: var(--r-heading-color);
|
104 |
+
transition: width 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
105 |
+
}
|
106 |
+
|
107 |
+
/* Enhanced image handling */
|
108 |
+
.slide-image {
|
109 |
+
max-height: 50vh;
|
110 |
+
width: auto;
|
111 |
+
margin: 20px auto;
|
112 |
+
border-radius: 12px;
|
113 |
+
box-shadow: 0 4px 20px rgba(0,0,0,0.1);
|
114 |
+
transition: transform 0.3s ease;
|
115 |
+
}
|
116 |
+
|
117 |
+
.slide-image:hover {
|
118 |
+
transform: scale(1.02);
|
119 |
+
}
|
120 |
+
|
121 |
+
/* Two-column layout */
|
122 |
+
.columns {
|
123 |
+
display: flex;
|
124 |
+
justify-content: space-between;
|
125 |
+
gap: 40px;
|
126 |
+
margin: 20px 0;
|
127 |
+
}
|
128 |
+
|
129 |
+
.column {
|
130 |
+
flex: 1;
|
131 |
+
}
|
132 |
+
|
133 |
+
/* Visual elements */
|
134 |
+
.highlight-box {
|
135 |
+
background: linear-gradient(135deg, rgba(9, 132, 227, 0.1), rgba(9, 132, 227, 0.05));
|
136 |
+
border-left: 4px solid var(--r-heading-color);
|
137 |
+
padding: 20px;
|
138 |
+
border-radius: 8px;
|
139 |
+
margin: 20px 0;
|
140 |
+
}
|
141 |
+
|
142 |
+
.icon-text {
|
143 |
+
display: flex;
|
144 |
+
align-items: center;
|
145 |
+
gap: 15px;
|
146 |
+
margin: 10px 0;
|
147 |
+
}
|
148 |
+
|
149 |
+
.icon-text i {
|
150 |
+
color: var(--r-heading-color);
|
151 |
+
font-size: 1.5em;
|
152 |
+
}
|
153 |
+
|
154 |
+
.stats-grid {
|
155 |
+
display: grid;
|
156 |
+
grid-template-columns: repeat(3, 1fr);
|
157 |
+
gap: 20px;
|
158 |
+
margin: 20px 0;
|
159 |
+
}
|
160 |
+
|
161 |
+
.stat-card {
|
162 |
+
background: white;
|
163 |
+
padding: 20px;
|
164 |
+
border-radius: 12px;
|
165 |
+
text-align: center;
|
166 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
167 |
+
transition: transform 0.3s ease;
|
168 |
+
}
|
169 |
+
|
170 |
+
.stat-card:hover {
|
171 |
+
transform: translateY(-5px);
|
172 |
+
}
|
173 |
+
|
174 |
+
.stat-number {
|
175 |
+
font-size: 2.5em;
|
176 |
+
font-weight: bold;
|
177 |
+
color: var(--r-heading-color);
|
178 |
+
margin-bottom: 10px;
|
179 |
+
}
|
180 |
+
|
181 |
+
.progress-bar {
|
182 |
+
height: 8px;
|
183 |
+
background: rgba(9, 132, 227, 0.1);
|
184 |
+
border-radius: 4px;
|
185 |
+
overflow: hidden;
|
186 |
+
margin: 10px 0;
|
187 |
+
}
|
188 |
+
|
189 |
+
.progress-bar .fill {
|
190 |
+
height: 100%;
|
191 |
+
background: var(--r-heading-color);
|
192 |
+
transition: width 1s ease;
|
193 |
+
}
|
194 |
+
|
195 |
+
.chart-container {
|
196 |
+
position: relative;
|
197 |
+
width: 100%;
|
198 |
+
height: 300px;
|
199 |
+
background: rgba(255, 255, 255, 0.95);
|
200 |
+
padding: 20px;
|
201 |
+
border-radius: 12px;
|
202 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
203 |
+
}
|
204 |
+
|
205 |
+
.chart-caption {
|
206 |
+
text-align: center;
|
207 |
+
font-size: 0.9em;
|
208 |
+
color: #666;
|
209 |
+
margin-top: 10px;
|
210 |
+
}
|
211 |
+
|
212 |
+
.interactive-eye {
|
213 |
+
position: relative;
|
214 |
+
}
|
215 |
+
|
216 |
+
.eye-hotspots .hotspot {
|
217 |
+
position: absolute;
|
218 |
+
width: 20px;
|
219 |
+
height: 20px;
|
220 |
+
background: rgba(9, 132, 227, 0.5);
|
221 |
+
border-radius: 50%;
|
222 |
+
cursor: pointer;
|
223 |
+
transition: all 0.3s ease;
|
224 |
+
}
|
225 |
+
|
226 |
+
.eye-hotspots .hotspot:hover {
|
227 |
+
background: rgba(9, 132, 227, 0.8);
|
228 |
+
transform: scale(1.2);
|
229 |
+
}
|
230 |
+
|
231 |
+
.eye-hotspots .hotspot:hover::after {
|
232 |
+
content: attr(data-tooltip);
|
233 |
+
position: absolute;
|
234 |
+
bottom: 100%;
|
235 |
+
left: 50%;
|
236 |
+
transform: translateX(-50%);
|
237 |
+
background: rgba(0, 0, 0, 0.8);
|
238 |
+
color: white;
|
239 |
+
padding: 5px 10px;
|
240 |
+
border-radius: 4px;
|
241 |
+
font-size: 0.8em;
|
242 |
+
white-space: nowrap;
|
243 |
+
}
|
244 |
+
</style>
|
245 |
+
</head>
|
246 |
+
<body>
|
247 |
+
<div class="reveal">
|
248 |
+
<div class="slides">
|
249 |
+
|
250 |
+
<section class="title-slide">
|
251 |
+
<h1>Glaucoma: Understanding and Protecting Your Vision</h1>
|
252 |
+
<div class="columns">
|
253 |
+
<div class="column">
|
254 |
+
<div class="stat-grid">
|
255 |
+
<div class="stat-card">
|
256 |
+
<i class="fas fa-eye fa-2x" style="color: var(--r-heading-color)"></i>
|
257 |
+
<div class="stat-number">80M+</div>
|
258 |
+
<p>People Affected Globally</p>
|
259 |
+
</div>
|
260 |
+
<div class="stat-card">
|
261 |
+
<i class="fas fa-chart-line fa-2x" style="color: var(--r-heading-color)"></i>
|
262 |
+
<div class="stat-number">111.8M</div>
|
263 |
+
<p>Projected by 2040</p>
|
264 |
+
</div>
|
265 |
+
<div class="stat-card">
|
266 |
+
<i class="fas fa-clock fa-2x" style="color: var(--r-heading-color)"></i>
|
267 |
+
<div class="stat-number">50%</div>
|
268 |
+
<p>Cases Undiagnosed</p>
|
269 |
+
</div>
|
270 |
+
</div>
|
271 |
+
<div class="highlight-box">
|
272 |
+
<h3>Global Impact</h3>
|
273 |
+
<div class="progress-bar">
|
274 |
+
<div class="fill" style="width: 75%"></div>
|
275 |
+
</div>
|
276 |
+
<p>Leading cause of irreversible blindness worldwide</p>
|
277 |
+
</div>
|
278 |
+
</div>
|
279 |
+
<div class="column">
|
280 |
+
<div class="chart-container">
|
281 |
+
<canvas id="globalPrevalenceChart"></canvas>
|
282 |
+
</div>
|
283 |
+
</div>
|
284 |
+
</div>
|
285 |
+
</section>
|
286 |
+
|
287 |
+
<section>
|
288 |
+
<h2>What is Glaucoma?</h2>
|
289 |
+
<div class="columns">
|
290 |
+
<div class="column">
|
291 |
+
<div class="highlight-box">
|
292 |
+
<p>Glaucoma is a group of eye diseases that damage the optic nerve, often due to high intraocular pressure.</p>
|
293 |
+
<div class="stats-grid">
|
294 |
+
<div class="stat-item">
|
295 |
+
<span class="stat-number">50%</span>
|
296 |
+
<span class="stat-label">of cases are undiagnosed</span>
|
297 |
+
</div>
|
298 |
+
<div class="stat-item">
|
299 |
+
<span class="stat-number">2040</span>
|
300 |
+
<span class="stat-label">111.8M projected cases</span>
|
301 |
+
</div>
|
302 |
+
</div>
|
303 |
+
</div>
|
304 |
+
<div class="icon-text">
|
305 |
+
<i class="fas fa-exclamation-triangle"></i>
|
306 |
+
<p>Often called the "silent thief of sight"</p>
|
307 |
+
</div>
|
308 |
+
</div>
|
309 |
+
<div class="column">
|
310 |
+
<div class="interactive-eye">
|
311 |
+
<img src="https://www.nei.nih.gov/sites/default/files/2019-06/eye-anatomy_1.jpg"
|
312 |
+
alt="Eye Anatomy" class="slide-image">
|
313 |
+
<div class="eye-hotspots">
|
314 |
+
<div class="hotspot" style="top: 40%; left: 30%;" data-tooltip="Optic Nerve"></div>
|
315 |
+
<div class="hotspot" style="top: 35%; left: 60%;" data-tooltip="Trabecular Meshwork"></div>
|
316 |
+
<div class="hotspot" style="top: 45%; left: 45%;" data-tooltip="Anterior Chamber"></div>
|
317 |
+
</div>
|
318 |
+
</div>
|
319 |
+
</div>
|
320 |
+
</div>
|
321 |
+
</section>
|
322 |
+
|
323 |
+
<section>
|
324 |
+
<h2>Types of Glaucoma</h2>
|
325 |
+
<div class="columns">
|
326 |
+
<div class="column">
|
327 |
+
<ul>
|
328 |
+
<li><i class="fas fa-angle-right"></i> <strong>Open-Angle Glaucoma:</strong> Most common form</li>
|
329 |
+
<li><i class="fas fa-angle-right"></i> <strong>Angle-Closure Glaucoma:</strong> Medical emergency</li>
|
330 |
+
<li><i class="fas fa-angle-right"></i> <strong>Normal-Tension Glaucoma:</strong> Damage despite normal pressure</li>
|
331 |
+
</ul>
|
332 |
+
</div>
|
333 |
+
<div class="column">
|
334 |
+
<img src="https://images.unsplash.com/photo-1590486803833-1c5dc8ddd4c8?auto=format&fit=crop&w=800&q=80"
|
335 |
+
alt="Eye Diagram" class="slide-image">
|
336 |
+
</div>
|
337 |
+
</div>
|
338 |
+
</section>
|
339 |
+
|
340 |
+
<section data-background-gradient="linear-gradient(to bottom right, #ffffff, #f0f9ff)">
|
341 |
+
<h2>Risk Factors</h2>
|
342 |
+
<div class="columns">
|
343 |
+
<div class="column">
|
344 |
+
<div class="highlight-box">
|
345 |
+
<h3>Primary Risk Factors</h3>
|
346 |
+
<ul>
|
347 |
+
<li><i class="fas fa-user"></i> Age over 60</li>
|
348 |
+
<li><i class="fas fa-dna"></i> Family history</li>
|
349 |
+
<li><i class="fas fa-globe"></i> Ethnicity</li>
|
350 |
+
</ul>
|
351 |
+
</div>
|
352 |
+
</div>
|
353 |
+
<div class="column">
|
354 |
+
<div class="highlight-box">
|
355 |
+
<h3>Medical Risk Factors</h3>
|
356 |
+
<ul>
|
357 |
+
<li><i class="fas fa-heartbeat"></i> High blood pressure</li>
|
358 |
+
<li><i class="fas fa-prescription"></i> Diabetes</li>
|
359 |
+
<li><i class="fas fa-pills"></i> Long-term steroid use</li>
|
360 |
+
</ul>
|
361 |
+
</div>
|
362 |
+
</div>
|
363 |
+
</div>
|
364 |
+
</section>
|
365 |
+
|
366 |
+
<section>
|
367 |
+
<h2>Symptoms of Glaucoma</h2>
|
368 |
+
<p>Often, there are no early symptoms in open-angle glaucoma. Vision loss is slow and gradual. Angle-closure glaucoma can present with sudden symptoms.</p>
|
369 |
+
<ul>
|
370 |
+
<li><strong>Gradual peripheral vision loss (Open-angle)</strong></li>
|
371 |
+
<li><strong>Tunnel vision in advanced stages</strong></li>
|
372 |
+
<li><strong>Severe eye pain (Angle-closure)</strong></li>
|
373 |
+
<li><strong>Nausea and vomiting (Angle-closure)</strong></li>
|
374 |
+
<li><strong>Blurred vision</strong></li>
|
375 |
+
<li><strong>Halos around lights</strong></li>
|
376 |
+
<li><strong>Redness of the eye</strong></li>
|
377 |
+
</ul>
|
378 |
+
<img src="https://www.aao.org/asset.axd?id=48445490-a773-4181-889d-194a1989993b&t=637848477549500000" alt="Glaucoma Symptoms" style="max-height: 350px;">
|
379 |
+
<p style="font-size: 0.7em; color: #777;">Image source: aao.org</p>
|
380 |
+
</section>
|
381 |
+
|
382 |
+
<section>
|
383 |
+
<h2>Diagnosis</h2>
|
384 |
+
<p>Regular eye exams are crucial for early detection. Glaucoma can be diagnosed through various tests:</p>
|
385 |
+
<ol>
|
386 |
+
<li><strong>Tonometry:</strong> Measures intraocular pressure (IOP).</li>
|
387 |
+
<li><strong>Ophthalmoscopy:</strong> Examines the optic nerve for damage.</li>
|
388 |
+
<li><strong>Perimetry (Visual Field Test):</strong> Checks for peripheral vision loss.</li>
|
389 |
+
<li><strong>Gonioscopy:</strong> Inspects the drainage angle of the eye.</li>
|
390 |
+
<li><strong>Pachymetry:</strong> Measures corneal thickness.</li>
|
391 |
+
<li><strong>Optical Coherence Tomography (OCT):</strong> Imaging of the optic nerve and retina.</li>
|
392 |
+
</ol>
|
393 |
+
<img src="https://www.glaucoma.org/wp-content/uploads/2023/08/glaucoma-diagnosis-tests.jpg" alt="Glaucoma Diagnosis Tests" style="max-height: 300px;">
|
394 |
+
<p style="font-size: 0.7em; color: #777;">Image source: glaucoma.org</p>
|
395 |
+
</section>
|
396 |
+
|
397 |
+
<section>
|
398 |
+
<h2>Treatment: Eye Drops</h2>
|
399 |
+
<p>Medicated eye drops are the most common initial treatment. They help to lower eye pressure.</p>
|
400 |
+
<ul>
|
401 |
+
<li><strong>Prostaglandins:</strong> Increase fluid outflow.</li>
|
402 |
+
<li><strong>Beta-blockers:</strong> Reduce fluid production.</li>
|
403 |
+
<li><strong>Alpha-adrenergic agonists:</strong> Reduce fluid production and increase outflow.</li>
|
404 |
+
<li><strong>Carbonic anhydrase inhibitors:</strong> Reduce fluid production.</li>
|
405 |
+
<li><strong>Rho kinase inhibitors:</strong> Increase fluid outflow.</li>
|
406 |
+
</ul>
|
407 |
+
<img src="https://www.rxsafe.com/wp-content/uploads/2020/07/iStock-1142459298-1024x683.jpg" alt="Eye Drops for Glaucoma" style="max-height: 350px;">
|
408 |
+
<p style="font-size: 0.7em; color: #777;">Image source: rxsafe.com</p>
|
409 |
+
</section>
|
410 |
+
|
411 |
+
<section>
|
412 |
+
<h2>Treatment: Laser Therapy</h2>
|
413 |
+
<p>Laser procedures can help increase fluid drainage in the eye.</p>
|
414 |
+
<ul>
|
415 |
+
<li><strong>Trabeculoplasty (SLT/ALT):</strong> For open-angle glaucoma, to improve drainage.</li>
|
416 |
+
<li><strong>Iridotomy:</strong> For angle-closure glaucoma, to create a hole in the iris for fluid flow.</li>
|
417 |
+
<li><strong>Cyclophotocoagulation:</strong> To reduce fluid production in severe cases.</li>
|
418 |
+
</ul>
|
419 |
+
<img src="https://www.researchgate.net/publication/344019914/figure/fig1/AS:933628888879104@1599185878481/Selective-laser-trabeculoplasty-SLT-procedure-A-SLT-laser-delivery-system-B-SLT.png" alt="Laser Therapy for Glaucoma" style="max-height: 300px;">
|
420 |
+
<p style="font-size: 0.7em; color: #777;">Image source: researchgate.net</p>
|
421 |
+
</section>
|
422 |
+
|
423 |
+
<section>
|
424 |
+
<h2>Treatment: Surgery</h2>
|
425 |
+
<p>Surgical options are considered when eye drops and laser therapy are not sufficient.</p>
|
426 |
+
<ul>
|
427 |
+
<li><strong>Trabeculectomy:</strong> Creates a new drainage channel.</li>
|
428 |
+
<li><strong>Drainage Implants (Tube Shunts):</strong> Insert a tube to drain fluid.</li>
|
429 |
+
<li><strong>Minimally Invasive Glaucoma Surgery (MIGS):</strong> Less invasive procedures with faster recovery.</li>
|
430 |
+
</ul>
|
431 |
+
<img src="https://eyecareassociates.net/wp-content/uploads/2020/12/MIGS-surgery-options-for-glaucoma.png" alt="Glaucoma Surgery" style="max-height: 350px;">
|
432 |
+
<p style="font-size: 0.7em; color: #777;">Image source: eyecareassociates.net</p>
|
433 |
+
</section>
|
434 |
+
|
435 |
+
<section>
|
436 |
+
<h2>Living with Glaucoma</h2>
|
437 |
+
<p>Glaucoma is a chronic condition requiring ongoing management. Early detection and consistent treatment are key to preserving vision.</p>
|
438 |
+
<ul>
|
439 |
+
<li><strong>Regular eye exams are vital.</strong></li>
|
440 |
+
<li><strong>Adhere to prescribed treatments.</strong></li>
|
441 |
+
<li><strong>Maintain a healthy lifestyle.</strong></li>
|
442 |
+
<li><strong>Support groups and resources are available.</strong></li>
|
443 |
+
</ul>
|
444 |
+
<p><strong>Protect your vision. Get regular eye checks!</strong></p>
|
445 |
+
<img src="https://www.brightfocus.org/sites/default/files/styles/hero_image_1200x400/public/BrightFocus-Glaucoma-Hero-1200x400.jpg?itok=TsW_bDmz" alt="Living with Glaucoma" style="max-height: 300px;">
|
446 |
+
<p style="font-size: 0.7em; color: #777;">Image source: brightfocus.org</p>
|
447 |
+
</section>
|
448 |
+
|
449 |
+
</div>
|
450 |
+
</div>
|
451 |
+
|
452 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.js"></script>
|
453 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/zoom/zoom.min.js"></script>
|
454 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/notes/notes.min.js"></script>
|
455 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/search/search.min.js"></script>
|
456 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/markdown/markdown.min.js"></script>
|
457 |
+
<script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
|
458 |
+
|
459 |
+
<script>
|
460 |
+
Reveal.initialize({
|
461 |
+
// Modern configuration
|
462 |
+
hash: true,
|
463 |
+
mouseWheel: false,
|
464 |
+
transition: 'slide',
|
465 |
+
transitionSpeed: 'default',
|
466 |
+
backgroundTransition: 'fade',
|
467 |
+
autoPlayMedia: true,
|
468 |
+
|
469 |
+
// Enhanced animation settings
|
470 |
+
viewDistance: 3,
|
471 |
+
autoSlide: 0,
|
472 |
+
autoSlideStoppable: true,
|
473 |
+
|
474 |
+
// Improved navigation
|
475 |
+
controls: true,
|
476 |
+
controlsTutorial: true,
|
477 |
+
controlsLayout: 'bottom-right',
|
478 |
+
controlsBackArrows: 'faded',
|
479 |
+
progress: true,
|
480 |
+
center: true,
|
481 |
+
|
482 |
+
// Modern responsive design
|
483 |
+
width: 1920,
|
484 |
+
height: 1080,
|
485 |
+
margin: 0.04,
|
486 |
+
minScale: 0.2,
|
487 |
+
maxScale: 2.0,
|
488 |
+
|
489 |
+
// Keyboard navigation
|
490 |
+
keyboard: {
|
491 |
+
13: 'next', // Enter
|
492 |
+
27: () => { }, // Escape (disable default ESC behavior)
|
493 |
+
32: 'next', // Space
|
494 |
+
37: 'prev', // Left arrow
|
495 |
+
38: 'prev', // Up arrow
|
496 |
+
39: 'next', // Right arrow
|
497 |
+
40: 'next' // Down arrow
|
498 |
+
},
|
499 |
+
|
500 |
+
// Plugins
|
501 |
+
plugins: [ RevealZoom, RevealNotes, RevealSearch, RevealMarkdown ],
|
502 |
+
|
503 |
+
// Progress bar styling
|
504 |
+
progress: {
|
505 |
+
color: '#0984e3',
|
506 |
+
height: '4px'
|
507 |
+
}
|
508 |
+
});
|
509 |
+
|
510 |
+
// Add keyboard shortcut for overview mode
|
511 |
+
document.addEventListener('keydown', function(event) {
|
512 |
+
if (event.key === 'o') {
|
513 |
+
Reveal.toggleOverview();
|
514 |
+
}
|
515 |
+
});
|
516 |
+
|
517 |
+
// Add smooth scroll behavior
|
518 |
+
Reveal.configure({
|
519 |
+
slideNumber: 'c/t',
|
520 |
+
touch: true,
|
521 |
+
hideInactiveCursor: true,
|
522 |
+
hideCursorTime: 3000
|
523 |
+
});
|
524 |
+
|
525 |
+
// Add animation on slide change
|
526 |
+
Reveal.on('slidechanged', event => {
|
527 |
+
const currentSlide = event.currentSlide;
|
528 |
+
const images = currentSlide.querySelectorAll('.slide-image');
|
529 |
+
images.forEach(img => {
|
530 |
+
img.style.opacity = 0;
|
531 |
+
setTimeout(() => {
|
532 |
+
img.style.opacity = 1;
|
533 |
+
}, 200);
|
534 |
+
});
|
535 |
+
});
|
536 |
+
|
537 |
+
// Enhanced chart initialization
|
538 |
+
document.addEventListener('DOMContentLoaded', function() {
|
539 |
+
const ctx = document.getElementById('globalPrevalenceChart').getContext('2d');
|
540 |
+
new Chart(ctx, {
|
541 |
+
type: 'doughnut',
|
542 |
+
data: {
|
543 |
+
labels: ['Asia Pacific', 'Africa', 'Europe', 'Americas', 'Middle East'],
|
544 |
+
datasets: [{
|
545 |
+
data: [45, 20, 15, 15, 5],
|
546 |
+
backgroundColor: [
|
547 |
+
'#0984e3',
|
548 |
+
'#00b894',
|
549 |
+
'#6c5ce7',
|
550 |
+
'#fdcb6e',
|
551 |
+
'#e17055'
|
552 |
+
],
|
553 |
+
borderWidth: 2,
|
554 |
+
borderColor: 'white'
|
555 |
+
}]
|
556 |
+
},
|
557 |
+
options: {
|
558 |
+
responsive: true,
|
559 |
+
maintainAspectRatio: false,
|
560 |
+
plugins: {
|
561 |
+
legend: {
|
562 |
+
position: 'right',
|
563 |
+
labels: {
|
564 |
+
padding: 20,
|
565 |
+
font: {
|
566 |
+
size: 14
|
567 |
+
}
|
568 |
+
}
|
569 |
+
},
|
570 |
+
title: {
|
571 |
+
display: true,
|
572 |
+
text: 'Global Glaucoma Distribution (2023)',
|
573 |
+
font: {
|
574 |
+
size: 16,
|
575 |
+
weight: 'bold'
|
576 |
+
}
|
577 |
+
}
|
578 |
+
},
|
579 |
+
animation: {
|
580 |
+
animateScale: true,
|
581 |
+
animateRotate: true
|
582 |
+
}
|
583 |
+
}
|
584 |
+
});
|
585 |
+
});
|
586 |
+
</script>
|
587 |
+
</body>
|
588 |
+
</html>
|
.history/index_20250131185948.html
ADDED
@@ -0,0 +1,588 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
<!DOCTYPE html>
|
2 |
+
<html>
|
3 |
+
<head>
|
4 |
+
<title>Glaucoma: A Comprehensive Overview</title>
|
5 |
+
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
6 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.css">
|
7 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/theme/white.min.css">
|
8 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
|
9 |
+
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/chart.js@4.4.1/dist/chart.min.css">
|
10 |
+
<style>
|
11 |
+
:root {
|
12 |
+
--r-main-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
13 |
+
--r-heading-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
14 |
+
--r-main-color: #2d3436;
|
15 |
+
--r-heading-color: #0984e3;
|
16 |
+
}
|
17 |
+
|
18 |
+
.reveal .slides {
|
19 |
+
text-align: left;
|
20 |
+
font-family: var(--r-main-font);
|
21 |
+
}
|
22 |
+
|
23 |
+
.reveal .slides section {
|
24 |
+
width: 100%;
|
25 |
+
height: 100%;
|
26 |
+
padding: 40px;
|
27 |
+
box-sizing: border-box;
|
28 |
+
display: flex;
|
29 |
+
flex-direction: column;
|
30 |
+
justify-content: center;
|
31 |
+
transition: transform 0.8s cubic-bezier(0.4, 0, 0.2, 1),
|
32 |
+
opacity 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
33 |
+
}
|
34 |
+
|
35 |
+
.reveal h1, .reveal h2 {
|
36 |
+
color: var(--r-heading-color);
|
37 |
+
font-weight: 600;
|
38 |
+
letter-spacing: -0.02em;
|
39 |
+
margin-bottom: 1em;
|
40 |
+
}
|
41 |
+
|
42 |
+
.reveal p, .reveal li {
|
43 |
+
font-size: 1.1em;
|
44 |
+
line-height: 1.6;
|
45 |
+
color: var(--r-main-color);
|
46 |
+
}
|
47 |
+
|
48 |
+
.reveal ul, .reveal ol {
|
49 |
+
background: #f8f9fa;
|
50 |
+
border-radius: 8px;
|
51 |
+
padding: 20px 40px;
|
52 |
+
box-shadow: 0 2px 8px rgba(0,0,0,0.05);
|
53 |
+
}
|
54 |
+
|
55 |
+
.image-container {
|
56 |
+
background: white;
|
57 |
+
padding: 20px;
|
58 |
+
border-radius: 12px;
|
59 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
60 |
+
margin: 20px 0;
|
61 |
+
}
|
62 |
+
|
63 |
+
.image-container img {
|
64 |
+
max-width: 100%;
|
65 |
+
border-radius: 8px;
|
66 |
+
display: block;
|
67 |
+
margin: 0 auto;
|
68 |
+
}
|
69 |
+
|
70 |
+
.image-caption {
|
71 |
+
text-align: center;
|
72 |
+
color: #636e72;
|
73 |
+
font-size: 0.8em;
|
74 |
+
margin-top: 10px;
|
75 |
+
}
|
76 |
+
|
77 |
+
/* Navigation buttons styling */
|
78 |
+
.reveal .controls {
|
79 |
+
color: var(--r-heading-color);
|
80 |
+
}
|
81 |
+
|
82 |
+
.reveal .controls button {
|
83 |
+
padding: 12px;
|
84 |
+
background: rgba(255, 255, 255, 0.9);
|
85 |
+
border-radius: 50%;
|
86 |
+
transition: all 0.3s ease;
|
87 |
+
box-shadow: 0 2px 6px rgba(0,0,0,0.1);
|
88 |
+
}
|
89 |
+
|
90 |
+
.reveal .controls button:hover {
|
91 |
+
background: var(--r-heading-color);
|
92 |
+
color: white;
|
93 |
+
transform: scale(1.1);
|
94 |
+
}
|
95 |
+
|
96 |
+
/* Progress bar enhancement */
|
97 |
+
.reveal .progress {
|
98 |
+
height: 4px;
|
99 |
+
background: rgba(9, 132, 227, 0.2);
|
100 |
+
}
|
101 |
+
|
102 |
+
.reveal .progress span {
|
103 |
+
background: var(--r-heading-color);
|
104 |
+
transition: width 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
105 |
+
}
|
106 |
+
|
107 |
+
/* Enhanced image handling */
|
108 |
+
.slide-image {
|
109 |
+
max-height: 50vh;
|
110 |
+
width: auto;
|
111 |
+
margin: 20px auto;
|
112 |
+
border-radius: 12px;
|
113 |
+
box-shadow: 0 4px 20px rgba(0,0,0,0.1);
|
114 |
+
transition: transform 0.3s ease;
|
115 |
+
}
|
116 |
+
|
117 |
+
.slide-image:hover {
|
118 |
+
transform: scale(1.02);
|
119 |
+
}
|
120 |
+
|
121 |
+
/* Two-column layout */
|
122 |
+
.columns {
|
123 |
+
display: flex;
|
124 |
+
justify-content: space-between;
|
125 |
+
gap: 40px;
|
126 |
+
margin: 20px 0;
|
127 |
+
}
|
128 |
+
|
129 |
+
.column {
|
130 |
+
flex: 1;
|
131 |
+
}
|
132 |
+
|
133 |
+
/* Visual elements */
|
134 |
+
.highlight-box {
|
135 |
+
background: linear-gradient(135deg, rgba(9, 132, 227, 0.1), rgba(9, 132, 227, 0.05));
|
136 |
+
border-left: 4px solid var(--r-heading-color);
|
137 |
+
padding: 20px;
|
138 |
+
border-radius: 8px;
|
139 |
+
margin: 20px 0;
|
140 |
+
}
|
141 |
+
|
142 |
+
.icon-text {
|
143 |
+
display: flex;
|
144 |
+
align-items: center;
|
145 |
+
gap: 15px;
|
146 |
+
margin: 10px 0;
|
147 |
+
}
|
148 |
+
|
149 |
+
.icon-text i {
|
150 |
+
color: var(--r-heading-color);
|
151 |
+
font-size: 1.5em;
|
152 |
+
}
|
153 |
+
|
154 |
+
.stats-grid {
|
155 |
+
display: grid;
|
156 |
+
grid-template-columns: repeat(3, 1fr);
|
157 |
+
gap: 20px;
|
158 |
+
margin: 20px 0;
|
159 |
+
}
|
160 |
+
|
161 |
+
.stat-card {
|
162 |
+
background: white;
|
163 |
+
padding: 20px;
|
164 |
+
border-radius: 12px;
|
165 |
+
text-align: center;
|
166 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
167 |
+
transition: transform 0.3s ease;
|
168 |
+
}
|
169 |
+
|
170 |
+
.stat-card:hover {
|
171 |
+
transform: translateY(-5px);
|
172 |
+
}
|
173 |
+
|
174 |
+
.stat-number {
|
175 |
+
font-size: 2.5em;
|
176 |
+
font-weight: bold;
|
177 |
+
color: var(--r-heading-color);
|
178 |
+
margin-bottom: 10px;
|
179 |
+
}
|
180 |
+
|
181 |
+
.progress-bar {
|
182 |
+
height: 8px;
|
183 |
+
background: rgba(9, 132, 227, 0.1);
|
184 |
+
border-radius: 4px;
|
185 |
+
overflow: hidden;
|
186 |
+
margin: 10px 0;
|
187 |
+
}
|
188 |
+
|
189 |
+
.progress-bar .fill {
|
190 |
+
height: 100%;
|
191 |
+
background: var(--r-heading-color);
|
192 |
+
transition: width 1s ease;
|
193 |
+
}
|
194 |
+
|
195 |
+
.chart-container {
|
196 |
+
position: relative;
|
197 |
+
width: 100%;
|
198 |
+
height: 300px;
|
199 |
+
background: rgba(255, 255, 255, 0.95);
|
200 |
+
padding: 20px;
|
201 |
+
border-radius: 12px;
|
202 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
203 |
+
}
|
204 |
+
|
205 |
+
.chart-caption {
|
206 |
+
text-align: center;
|
207 |
+
font-size: 0.9em;
|
208 |
+
color: #666;
|
209 |
+
margin-top: 10px;
|
210 |
+
}
|
211 |
+
|
212 |
+
.interactive-eye {
|
213 |
+
position: relative;
|
214 |
+
}
|
215 |
+
|
216 |
+
.eye-hotspots .hotspot {
|
217 |
+
position: absolute;
|
218 |
+
width: 20px;
|
219 |
+
height: 20px;
|
220 |
+
background: rgba(9, 132, 227, 0.5);
|
221 |
+
border-radius: 50%;
|
222 |
+
cursor: pointer;
|
223 |
+
transition: all 0.3s ease;
|
224 |
+
}
|
225 |
+
|
226 |
+
.eye-hotspots .hotspot:hover {
|
227 |
+
background: rgba(9, 132, 227, 0.8);
|
228 |
+
transform: scale(1.2);
|
229 |
+
}
|
230 |
+
|
231 |
+
.eye-hotspots .hotspot:hover::after {
|
232 |
+
content: attr(data-tooltip);
|
233 |
+
position: absolute;
|
234 |
+
bottom: 100%;
|
235 |
+
left: 50%;
|
236 |
+
transform: translateX(-50%);
|
237 |
+
background: rgba(0, 0, 0, 0.8);
|
238 |
+
color: white;
|
239 |
+
padding: 5px 10px;
|
240 |
+
border-radius: 4px;
|
241 |
+
font-size: 0.8em;
|
242 |
+
white-space: nowrap;
|
243 |
+
}
|
244 |
+
</style>
|
245 |
+
</head>
|
246 |
+
<body>
|
247 |
+
<div class="reveal">
|
248 |
+
<div class="slides">
|
249 |
+
|
250 |
+
<section class="title-slide">
|
251 |
+
<h1>Glaucoma: Understanding and Protecting Your Vision</h1>
|
252 |
+
<div class="columns">
|
253 |
+
<div class="column">
|
254 |
+
<div class="stat-grid">
|
255 |
+
<div class="stat-card">
|
256 |
+
<i class="fas fa-eye fa-2x" style="color: var(--r-heading-color)"></i>
|
257 |
+
<div class="stat-number">80M+</div>
|
258 |
+
<p>People Affected Globally</p>
|
259 |
+
</div>
|
260 |
+
<div class="stat-card">
|
261 |
+
<i class="fas fa-chart-line fa-2x" style="color: var(--r-heading-color)"></i>
|
262 |
+
<div class="stat-number">111.8M</div>
|
263 |
+
<p>Projected by 2040</p>
|
264 |
+
</div>
|
265 |
+
<div class="stat-card">
|
266 |
+
<i class="fas fa-clock fa-2x" style="color: var(--r-heading-color)"></i>
|
267 |
+
<div class="stat-number">50%</div>
|
268 |
+
<p>Cases Undiagnosed</p>
|
269 |
+
</div>
|
270 |
+
</div>
|
271 |
+
<div class="highlight-box">
|
272 |
+
<h3>Global Impact</h3>
|
273 |
+
<div class="progress-bar">
|
274 |
+
<div class="fill" style="width: 75%"></div>
|
275 |
+
</div>
|
276 |
+
<p>Leading cause of irreversible blindness worldwide</p>
|
277 |
+
</div>
|
278 |
+
</div>
|
279 |
+
<div class="column">
|
280 |
+
<div class="chart-container">
|
281 |
+
<canvas id="globalPrevalenceChart"></canvas>
|
282 |
+
</div>
|
283 |
+
</div>
|
284 |
+
</div>
|
285 |
+
</section>
|
286 |
+
|
287 |
+
<section>
|
288 |
+
<h2>What is Glaucoma?</h2>
|
289 |
+
<div class="columns">
|
290 |
+
<div class="column">
|
291 |
+
<div class="highlight-box">
|
292 |
+
<p>Glaucoma is a group of eye diseases that damage the optic nerve, often due to high intraocular pressure.</p>
|
293 |
+
<div class="stats-grid">
|
294 |
+
<div class="stat-item">
|
295 |
+
<span class="stat-number">50%</span>
|
296 |
+
<span class="stat-label">of cases are undiagnosed</span>
|
297 |
+
</div>
|
298 |
+
<div class="stat-item">
|
299 |
+
<span class="stat-number">2040</span>
|
300 |
+
<span class="stat-label">111.8M projected cases</span>
|
301 |
+
</div>
|
302 |
+
</div>
|
303 |
+
</div>
|
304 |
+
<div class="icon-text">
|
305 |
+
<i class="fas fa-exclamation-triangle"></i>
|
306 |
+
<p>Often called the "silent thief of sight"</p>
|
307 |
+
</div>
|
308 |
+
</div>
|
309 |
+
<div class="column">
|
310 |
+
<div class="interactive-eye">
|
311 |
+
<img src="https://www.nei.nih.gov/sites/default/files/2019-06/eye-anatomy_1.jpg"
|
312 |
+
alt="Eye Anatomy" class="slide-image">
|
313 |
+
<div class="eye-hotspots">
|
314 |
+
<div class="hotspot" style="top: 40%; left: 30%;" data-tooltip="Optic Nerve"></div>
|
315 |
+
<div class="hotspot" style="top: 35%; left: 60%;" data-tooltip="Trabecular Meshwork"></div>
|
316 |
+
<div class="hotspot" style="top: 45%; left: 45%;" data-tooltip="Anterior Chamber"></div>
|
317 |
+
</div>
|
318 |
+
</div>
|
319 |
+
</div>
|
320 |
+
</div>
|
321 |
+
</section>
|
322 |
+
|
323 |
+
<section>
|
324 |
+
<h2>Types of Glaucoma</h2>
|
325 |
+
<div class="columns">
|
326 |
+
<div class="column">
|
327 |
+
<ul>
|
328 |
+
<li><i class="fas fa-angle-right"></i> <strong>Open-Angle Glaucoma:</strong> Most common form</li>
|
329 |
+
<li><i class="fas fa-angle-right"></i> <strong>Angle-Closure Glaucoma:</strong> Medical emergency</li>
|
330 |
+
<li><i class="fas fa-angle-right"></i> <strong>Normal-Tension Glaucoma:</strong> Damage despite normal pressure</li>
|
331 |
+
</ul>
|
332 |
+
</div>
|
333 |
+
<div class="column">
|
334 |
+
<img src="https://images.unsplash.com/photo-1590486803833-1c5dc8ddd4c8?auto=format&fit=crop&w=800&q=80"
|
335 |
+
alt="Eye Diagram" class="slide-image">
|
336 |
+
</div>
|
337 |
+
</div>
|
338 |
+
</section>
|
339 |
+
|
340 |
+
<section data-background-gradient="linear-gradient(to bottom right, #ffffff, #f0f9ff)">
|
341 |
+
<h2>Risk Factors</h2>
|
342 |
+
<div class="columns">
|
343 |
+
<div class="column">
|
344 |
+
<div class="highlight-box">
|
345 |
+
<h3>Primary Risk Factors</h3>
|
346 |
+
<ul>
|
347 |
+
<li><i class="fas fa-user"></i> Age over 60</li>
|
348 |
+
<li><i class="fas fa-dna"></i> Family history</li>
|
349 |
+
<li><i class="fas fa-globe"></i> Ethnicity</li>
|
350 |
+
</ul>
|
351 |
+
</div>
|
352 |
+
</div>
|
353 |
+
<div class="column">
|
354 |
+
<div class="highlight-box">
|
355 |
+
<h3>Medical Risk Factors</h3>
|
356 |
+
<ul>
|
357 |
+
<li><i class="fas fa-heartbeat"></i> High blood pressure</li>
|
358 |
+
<li><i class="fas fa-prescription"></i> Diabetes</li>
|
359 |
+
<li><i class="fas fa-pills"></i> Long-term steroid use</li>
|
360 |
+
</ul>
|
361 |
+
</div>
|
362 |
+
</div>
|
363 |
+
</div>
|
364 |
+
</section>
|
365 |
+
|
366 |
+
<section>
|
367 |
+
<h2>Symptoms of Glaucoma</h2>
|
368 |
+
<p>Often, there are no early symptoms in open-angle glaucoma. Vision loss is slow and gradual. Angle-closure glaucoma can present with sudden symptoms.</p>
|
369 |
+
<ul>
|
370 |
+
<li><strong>Gradual peripheral vision loss (Open-angle)</strong></li>
|
371 |
+
<li><strong>Tunnel vision in advanced stages</strong></li>
|
372 |
+
<li><strong>Severe eye pain (Angle-closure)</strong></li>
|
373 |
+
<li><strong>Nausea and vomiting (Angle-closure)</strong></li>
|
374 |
+
<li><strong>Blurred vision</strong></li>
|
375 |
+
<li><strong>Halos around lights</strong></li>
|
376 |
+
<li><strong>Redness of the eye</strong></li>
|
377 |
+
</ul>
|
378 |
+
<img src="https://www.aao.org/asset.axd?id=48445490-a773-4181-889d-194a1989993b&t=637848477549500000" alt="Glaucoma Symptoms" style="max-height: 350px;">
|
379 |
+
<p style="font-size: 0.7em; color: #777;">Image source: aao.org</p>
|
380 |
+
</section>
|
381 |
+
|
382 |
+
<section>
|
383 |
+
<h2>Diagnosis</h2>
|
384 |
+
<p>Regular eye exams are crucial for early detection. Glaucoma can be diagnosed through various tests:</p>
|
385 |
+
<ol>
|
386 |
+
<li><strong>Tonometry:</strong> Measures intraocular pressure (IOP).</li>
|
387 |
+
<li><strong>Ophthalmoscopy:</strong> Examines the optic nerve for damage.</li>
|
388 |
+
<li><strong>Perimetry (Visual Field Test):</strong> Checks for peripheral vision loss.</li>
|
389 |
+
<li><strong>Gonioscopy:</strong> Inspects the drainage angle of the eye.</li>
|
390 |
+
<li><strong>Pachymetry:</strong> Measures corneal thickness.</li>
|
391 |
+
<li><strong>Optical Coherence Tomography (OCT):</strong> Imaging of the optic nerve and retina.</li>
|
392 |
+
</ol>
|
393 |
+
<img src="https://www.glaucoma.org/wp-content/uploads/2023/08/glaucoma-diagnosis-tests.jpg" alt="Glaucoma Diagnosis Tests" style="max-height: 300px;">
|
394 |
+
<p style="font-size: 0.7em; color: #777;">Image source: glaucoma.org</p>
|
395 |
+
</section>
|
396 |
+
|
397 |
+
<section>
|
398 |
+
<h2>Treatment: Eye Drops</h2>
|
399 |
+
<p>Medicated eye drops are the most common initial treatment. They help to lower eye pressure.</p>
|
400 |
+
<ul>
|
401 |
+
<li><strong>Prostaglandins:</strong> Increase fluid outflow.</li>
|
402 |
+
<li><strong>Beta-blockers:</strong> Reduce fluid production.</li>
|
403 |
+
<li><strong>Alpha-adrenergic agonists:</strong> Reduce fluid production and increase outflow.</li>
|
404 |
+
<li><strong>Carbonic anhydrase inhibitors:</strong> Reduce fluid production.</li>
|
405 |
+
<li><strong>Rho kinase inhibitors:</strong> Increase fluid outflow.</li>
|
406 |
+
</ul>
|
407 |
+
<img src="https://www.rxsafe.com/wp-content/uploads/2020/07/iStock-1142459298-1024x683.jpg" alt="Eye Drops for Glaucoma" style="max-height: 350px;">
|
408 |
+
<p style="font-size: 0.7em; color: #777;">Image source: rxsafe.com</p>
|
409 |
+
</section>
|
410 |
+
|
411 |
+
<section>
|
412 |
+
<h2>Treatment: Laser Therapy</h2>
|
413 |
+
<p>Laser procedures can help increase fluid drainage in the eye.</p>
|
414 |
+
<ul>
|
415 |
+
<li><strong>Trabeculoplasty (SLT/ALT):</strong> For open-angle glaucoma, to improve drainage.</li>
|
416 |
+
<li><strong>Iridotomy:</strong> For angle-closure glaucoma, to create a hole in the iris for fluid flow.</li>
|
417 |
+
<li><strong>Cyclophotocoagulation:</strong> To reduce fluid production in severe cases.</li>
|
418 |
+
</ul>
|
419 |
+
<img src="https://www.researchgate.net/publication/344019914/figure/fig1/AS:933628888879104@1599185878481/Selective-laser-trabeculoplasty-SLT-procedure-A-SLT-laser-delivery-system-B-SLT.png" alt="Laser Therapy for Glaucoma" style="max-height: 300px;">
|
420 |
+
<p style="font-size: 0.7em; color: #777;">Image source: researchgate.net</p>
|
421 |
+
</section>
|
422 |
+
|
423 |
+
<section>
|
424 |
+
<h2>Treatment: Surgery</h2>
|
425 |
+
<p>Surgical options are considered when eye drops and laser therapy are not sufficient.</p>
|
426 |
+
<ul>
|
427 |
+
<li><strong>Trabeculectomy:</strong> Creates a new drainage channel.</li>
|
428 |
+
<li><strong>Drainage Implants (Tube Shunts):</strong> Insert a tube to drain fluid.</li>
|
429 |
+
<li><strong>Minimally Invasive Glaucoma Surgery (MIGS):</strong> Less invasive procedures with faster recovery.</li>
|
430 |
+
</ul>
|
431 |
+
<img src="https://eyecareassociates.net/wp-content/uploads/2020/12/MIGS-surgery-options-for-glaucoma.png" alt="Glaucoma Surgery" style="max-height: 350px;">
|
432 |
+
<p style="font-size: 0.7em; color: #777;">Image source: eyecareassociates.net</p>
|
433 |
+
</section>
|
434 |
+
|
435 |
+
<section>
|
436 |
+
<h2>Living with Glaucoma</h2>
|
437 |
+
<p>Glaucoma is a chronic condition requiring ongoing management. Early detection and consistent treatment are key to preserving vision.</p>
|
438 |
+
<ul>
|
439 |
+
<li><strong>Regular eye exams are vital.</strong></li>
|
440 |
+
<li><strong>Adhere to prescribed treatments.</strong></li>
|
441 |
+
<li><strong>Maintain a healthy lifestyle.</strong></li>
|
442 |
+
<li><strong>Support groups and resources are available.</strong></li>
|
443 |
+
</ul>
|
444 |
+
<p><strong>Protect your vision. Get regular eye checks!</strong></p>
|
445 |
+
<img src="https://www.brightfocus.org/sites/default/files/styles/hero_image_1200x400/public/BrightFocus-Glaucoma-Hero-1200x400.jpg?itok=TsW_bDmz" alt="Living with Glaucoma" style="max-height: 300px;">
|
446 |
+
<p style="font-size: 0.7em; color: #777;">Image source: brightfocus.org</p>
|
447 |
+
</section>
|
448 |
+
|
449 |
+
</div>
|
450 |
+
</div>
|
451 |
+
|
452 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.js"></script>
|
453 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/zoom/zoom.min.js"></script>
|
454 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/notes/notes.min.js"></script>
|
455 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/search/search.min.js"></script>
|
456 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/markdown/markdown.min.js"></script>
|
457 |
+
<script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
|
458 |
+
|
459 |
+
<script>
|
460 |
+
Reveal.initialize({
|
461 |
+
// Modern configuration
|
462 |
+
hash: true,
|
463 |
+
mouseWheel: false,
|
464 |
+
transition: 'slide',
|
465 |
+
transitionSpeed: 'default',
|
466 |
+
backgroundTransition: 'fade',
|
467 |
+
autoPlayMedia: true,
|
468 |
+
|
469 |
+
// Enhanced animation settings
|
470 |
+
viewDistance: 3,
|
471 |
+
autoSlide: 0,
|
472 |
+
autoSlideStoppable: true,
|
473 |
+
|
474 |
+
// Improved navigation
|
475 |
+
controls: true,
|
476 |
+
controlsTutorial: true,
|
477 |
+
controlsLayout: 'bottom-right',
|
478 |
+
controlsBackArrows: 'faded',
|
479 |
+
progress: true,
|
480 |
+
center: true,
|
481 |
+
|
482 |
+
// Modern responsive design
|
483 |
+
width: 1920,
|
484 |
+
height: 1080,
|
485 |
+
margin: 0.04,
|
486 |
+
minScale: 0.2,
|
487 |
+
maxScale: 2.0,
|
488 |
+
|
489 |
+
// Keyboard navigation
|
490 |
+
keyboard: {
|
491 |
+
13: 'next', // Enter
|
492 |
+
27: () => { }, // Escape (disable default ESC behavior)
|
493 |
+
32: 'next', // Space
|
494 |
+
37: 'prev', // Left arrow
|
495 |
+
38: 'prev', // Up arrow
|
496 |
+
39: 'next', // Right arrow
|
497 |
+
40: 'next' // Down arrow
|
498 |
+
},
|
499 |
+
|
500 |
+
// Plugins
|
501 |
+
plugins: [ RevealZoom, RevealNotes, RevealSearch, RevealMarkdown ],
|
502 |
+
|
503 |
+
// Progress bar styling
|
504 |
+
progress: {
|
505 |
+
color: '#0984e3',
|
506 |
+
height: '4px'
|
507 |
+
}
|
508 |
+
});
|
509 |
+
|
510 |
+
// Add keyboard shortcut for overview mode
|
511 |
+
document.addEventListener('keydown', function(event) {
|
512 |
+
if (event.key === 'o') {
|
513 |
+
Reveal.toggleOverview();
|
514 |
+
}
|
515 |
+
});
|
516 |
+
|
517 |
+
// Add smooth scroll behavior
|
518 |
+
Reveal.configure({
|
519 |
+
slideNumber: 'c/t',
|
520 |
+
touch: true,
|
521 |
+
hideInactiveCursor: true,
|
522 |
+
hideCursorTime: 3000
|
523 |
+
});
|
524 |
+
|
525 |
+
// Add animation on slide change
|
526 |
+
Reveal.on('slidechanged', event => {
|
527 |
+
const currentSlide = event.currentSlide;
|
528 |
+
const images = currentSlide.querySelectorAll('.slide-image');
|
529 |
+
images.forEach(img => {
|
530 |
+
img.style.opacity = 0;
|
531 |
+
setTimeout(() => {
|
532 |
+
img.style.opacity = 1;
|
533 |
+
}, 200);
|
534 |
+
});
|
535 |
+
});
|
536 |
+
|
537 |
+
// Enhanced chart initialization
|
538 |
+
document.addEventListener('DOMContentLoaded', function() {
|
539 |
+
const ctx = document.getElementById('globalPrevalenceChart').getContext('2d');
|
540 |
+
new Chart(ctx, {
|
541 |
+
type: 'doughnut',
|
542 |
+
data: {
|
543 |
+
labels: ['Asia Pacific', 'Africa', 'Europe', 'Americas', 'Middle East'],
|
544 |
+
datasets: [{
|
545 |
+
data: [45, 20, 15, 15, 5],
|
546 |
+
backgroundColor: [
|
547 |
+
'#0984e3',
|
548 |
+
'#00b894',
|
549 |
+
'#6c5ce7',
|
550 |
+
'#fdcb6e',
|
551 |
+
'#e17055'
|
552 |
+
],
|
553 |
+
borderWidth: 2,
|
554 |
+
borderColor: 'white'
|
555 |
+
}]
|
556 |
+
},
|
557 |
+
options: {
|
558 |
+
responsive: true,
|
559 |
+
maintainAspectRatio: false,
|
560 |
+
plugins: {
|
561 |
+
legend: {
|
562 |
+
position: 'right',
|
563 |
+
labels: {
|
564 |
+
padding: 20,
|
565 |
+
font: {
|
566 |
+
size: 14
|
567 |
+
}
|
568 |
+
}
|
569 |
+
},
|
570 |
+
title: {
|
571 |
+
display: true,
|
572 |
+
text: 'Global Glaucoma Distribution (2023)',
|
573 |
+
font: {
|
574 |
+
size: 16,
|
575 |
+
weight: 'bold'
|
576 |
+
}
|
577 |
+
}
|
578 |
+
},
|
579 |
+
animation: {
|
580 |
+
animateScale: true,
|
581 |
+
animateRotate: true
|
582 |
+
}
|
583 |
+
}
|
584 |
+
});
|
585 |
+
});
|
586 |
+
</script>
|
587 |
+
</body>
|
588 |
+
</html>
|
index.html
CHANGED
@@ -6,6 +6,7 @@
|
|
6 |
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.css">
|
7 |
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/theme/white.min.css">
|
8 |
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
|
|
|
9 |
<style>
|
10 |
:root {
|
11 |
--r-main-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
@@ -20,7 +21,13 @@
|
|
20 |
}
|
21 |
|
22 |
.reveal .slides section {
|
|
|
|
|
23 |
padding: 40px;
|
|
|
|
|
|
|
|
|
24 |
transition: transform 0.8s cubic-bezier(0.4, 0, 0.2, 1),
|
25 |
opacity 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
26 |
}
|
@@ -143,28 +150,136 @@
|
|
143 |
color: var(--r-heading-color);
|
144 |
font-size: 1.5em;
|
145 |
}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146 |
</style>
|
147 |
</head>
|
148 |
<body>
|
149 |
<div class="reveal">
|
150 |
<div class="slides">
|
151 |
|
152 |
-
<section>
|
153 |
<h1>Glaucoma: Understanding and Protecting Your Vision</h1>
|
154 |
<div class="columns">
|
155 |
<div class="column">
|
156 |
-
<
|
157 |
-
|
158 |
-
|
159 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
160 |
</div>
|
161 |
-
<div class="
|
162 |
-
<
|
163 |
-
<
|
|
|
|
|
|
|
164 |
</div>
|
165 |
</div>
|
166 |
<div class="column">
|
167 |
-
|
|
|
|
|
168 |
</div>
|
169 |
</div>
|
170 |
</section>
|
@@ -175,6 +290,16 @@
|
|
175 |
<div class="column">
|
176 |
<div class="highlight-box">
|
177 |
<p>Glaucoma is a group of eye diseases that damage the optic nerve, often due to high intraocular pressure.</p>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178 |
</div>
|
179 |
<div class="icon-text">
|
180 |
<i class="fas fa-exclamation-triangle"></i>
|
@@ -182,8 +307,15 @@
|
|
182 |
</div>
|
183 |
</div>
|
184 |
<div class="column">
|
185 |
-
<
|
186 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
187 |
</div>
|
188 |
</div>
|
189 |
</section>
|
@@ -322,6 +454,7 @@
|
|
322 |
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/notes/notes.min.js"></script>
|
323 |
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/search/search.min.js"></script>
|
324 |
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/markdown/markdown.min.js"></script>
|
|
|
325 |
|
326 |
<script>
|
327 |
Reveal.initialize({
|
@@ -347,8 +480,8 @@
|
|
347 |
center: true,
|
348 |
|
349 |
// Modern responsive design
|
350 |
-
width:
|
351 |
-
height:
|
352 |
margin: 0.04,
|
353 |
minScale: 0.2,
|
354 |
maxScale: 2.0,
|
@@ -400,6 +533,56 @@
|
|
400 |
}, 200);
|
401 |
});
|
402 |
});
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
403 |
</script>
|
404 |
</body>
|
405 |
</html>
|
|
|
6 |
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.css">
|
7 |
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/theme/white.min.css">
|
8 |
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
|
9 |
+
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/chart.js@4.4.1/dist/chart.min.css">
|
10 |
<style>
|
11 |
:root {
|
12 |
--r-main-font: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
|
|
|
21 |
}
|
22 |
|
23 |
.reveal .slides section {
|
24 |
+
width: 100%;
|
25 |
+
height: 100%;
|
26 |
padding: 40px;
|
27 |
+
box-sizing: border-box;
|
28 |
+
display: flex;
|
29 |
+
flex-direction: column;
|
30 |
+
justify-content: center;
|
31 |
transition: transform 0.8s cubic-bezier(0.4, 0, 0.2, 1),
|
32 |
opacity 0.8s cubic-bezier(0.4, 0, 0.2, 1);
|
33 |
}
|
|
|
150 |
color: var(--r-heading-color);
|
151 |
font-size: 1.5em;
|
152 |
}
|
153 |
+
|
154 |
+
.stats-grid {
|
155 |
+
display: grid;
|
156 |
+
grid-template-columns: repeat(3, 1fr);
|
157 |
+
gap: 20px;
|
158 |
+
margin: 20px 0;
|
159 |
+
}
|
160 |
+
|
161 |
+
.stat-card {
|
162 |
+
background: white;
|
163 |
+
padding: 20px;
|
164 |
+
border-radius: 12px;
|
165 |
+
text-align: center;
|
166 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
167 |
+
transition: transform 0.3s ease;
|
168 |
+
}
|
169 |
+
|
170 |
+
.stat-card:hover {
|
171 |
+
transform: translateY(-5px);
|
172 |
+
}
|
173 |
+
|
174 |
+
.stat-number {
|
175 |
+
font-size: 2.5em;
|
176 |
+
font-weight: bold;
|
177 |
+
color: var(--r-heading-color);
|
178 |
+
margin-bottom: 10px;
|
179 |
+
}
|
180 |
+
|
181 |
+
.progress-bar {
|
182 |
+
height: 8px;
|
183 |
+
background: rgba(9, 132, 227, 0.1);
|
184 |
+
border-radius: 4px;
|
185 |
+
overflow: hidden;
|
186 |
+
margin: 10px 0;
|
187 |
+
}
|
188 |
+
|
189 |
+
.progress-bar .fill {
|
190 |
+
height: 100%;
|
191 |
+
background: var(--r-heading-color);
|
192 |
+
transition: width 1s ease;
|
193 |
+
}
|
194 |
+
|
195 |
+
.chart-container {
|
196 |
+
position: relative;
|
197 |
+
width: 100%;
|
198 |
+
height: 300px;
|
199 |
+
background: rgba(255, 255, 255, 0.95);
|
200 |
+
padding: 20px;
|
201 |
+
border-radius: 12px;
|
202 |
+
box-shadow: 0 4px 12px rgba(0,0,0,0.08);
|
203 |
+
}
|
204 |
+
|
205 |
+
.chart-caption {
|
206 |
+
text-align: center;
|
207 |
+
font-size: 0.9em;
|
208 |
+
color: #666;
|
209 |
+
margin-top: 10px;
|
210 |
+
}
|
211 |
+
|
212 |
+
.interactive-eye {
|
213 |
+
position: relative;
|
214 |
+
}
|
215 |
+
|
216 |
+
.eye-hotspots .hotspot {
|
217 |
+
position: absolute;
|
218 |
+
width: 20px;
|
219 |
+
height: 20px;
|
220 |
+
background: rgba(9, 132, 227, 0.5);
|
221 |
+
border-radius: 50%;
|
222 |
+
cursor: pointer;
|
223 |
+
transition: all 0.3s ease;
|
224 |
+
}
|
225 |
+
|
226 |
+
.eye-hotspots .hotspot:hover {
|
227 |
+
background: rgba(9, 132, 227, 0.8);
|
228 |
+
transform: scale(1.2);
|
229 |
+
}
|
230 |
+
|
231 |
+
.eye-hotspots .hotspot:hover::after {
|
232 |
+
content: attr(data-tooltip);
|
233 |
+
position: absolute;
|
234 |
+
bottom: 100%;
|
235 |
+
left: 50%;
|
236 |
+
transform: translateX(-50%);
|
237 |
+
background: rgba(0, 0, 0, 0.8);
|
238 |
+
color: white;
|
239 |
+
padding: 5px 10px;
|
240 |
+
border-radius: 4px;
|
241 |
+
font-size: 0.8em;
|
242 |
+
white-space: nowrap;
|
243 |
+
}
|
244 |
</style>
|
245 |
</head>
|
246 |
<body>
|
247 |
<div class="reveal">
|
248 |
<div class="slides">
|
249 |
|
250 |
+
<section class="title-slide">
|
251 |
<h1>Glaucoma: Understanding and Protecting Your Vision</h1>
|
252 |
<div class="columns">
|
253 |
<div class="column">
|
254 |
+
<div class="stat-grid">
|
255 |
+
<div class="stat-card">
|
256 |
+
<i class="fas fa-eye fa-2x" style="color: var(--r-heading-color)"></i>
|
257 |
+
<div class="stat-number">80M+</div>
|
258 |
+
<p>People Affected Globally</p>
|
259 |
+
</div>
|
260 |
+
<div class="stat-card">
|
261 |
+
<i class="fas fa-chart-line fa-2x" style="color: var(--r-heading-color)"></i>
|
262 |
+
<div class="stat-number">111.8M</div>
|
263 |
+
<p>Projected by 2040</p>
|
264 |
+
</div>
|
265 |
+
<div class="stat-card">
|
266 |
+
<i class="fas fa-clock fa-2x" style="color: var(--r-heading-color)"></i>
|
267 |
+
<div class="stat-number">50%</div>
|
268 |
+
<p>Cases Undiagnosed</p>
|
269 |
+
</div>
|
270 |
</div>
|
271 |
+
<div class="highlight-box">
|
272 |
+
<h3>Global Impact</h3>
|
273 |
+
<div class="progress-bar">
|
274 |
+
<div class="fill" style="width: 75%"></div>
|
275 |
+
</div>
|
276 |
+
<p>Leading cause of irreversible blindness worldwide</p>
|
277 |
</div>
|
278 |
</div>
|
279 |
<div class="column">
|
280 |
+
<div class="chart-container">
|
281 |
+
<canvas id="globalPrevalenceChart"></canvas>
|
282 |
+
</div>
|
283 |
</div>
|
284 |
</div>
|
285 |
</section>
|
|
|
290 |
<div class="column">
|
291 |
<div class="highlight-box">
|
292 |
<p>Glaucoma is a group of eye diseases that damage the optic nerve, often due to high intraocular pressure.</p>
|
293 |
+
<div class="stats-grid">
|
294 |
+
<div class="stat-item">
|
295 |
+
<span class="stat-number">50%</span>
|
296 |
+
<span class="stat-label">of cases are undiagnosed</span>
|
297 |
+
</div>
|
298 |
+
<div class="stat-item">
|
299 |
+
<span class="stat-number">2040</span>
|
300 |
+
<span class="stat-label">111.8M projected cases</span>
|
301 |
+
</div>
|
302 |
+
</div>
|
303 |
</div>
|
304 |
<div class="icon-text">
|
305 |
<i class="fas fa-exclamation-triangle"></i>
|
|
|
307 |
</div>
|
308 |
</div>
|
309 |
<div class="column">
|
310 |
+
<div class="interactive-eye">
|
311 |
+
<img src="https://www.nei.nih.gov/sites/default/files/2019-06/eye-anatomy_1.jpg"
|
312 |
+
alt="Eye Anatomy" class="slide-image">
|
313 |
+
<div class="eye-hotspots">
|
314 |
+
<div class="hotspot" style="top: 40%; left: 30%;" data-tooltip="Optic Nerve"></div>
|
315 |
+
<div class="hotspot" style="top: 35%; left: 60%;" data-tooltip="Trabecular Meshwork"></div>
|
316 |
+
<div class="hotspot" style="top: 45%; left: 45%;" data-tooltip="Anterior Chamber"></div>
|
317 |
+
</div>
|
318 |
+
</div>
|
319 |
</div>
|
320 |
</div>
|
321 |
</section>
|
|
|
454 |
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/notes/notes.min.js"></script>
|
455 |
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/search/search.min.js"></script>
|
456 |
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/plugin/markdown/markdown.min.js"></script>
|
457 |
+
<script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
|
458 |
|
459 |
<script>
|
460 |
Reveal.initialize({
|
|
|
480 |
center: true,
|
481 |
|
482 |
// Modern responsive design
|
483 |
+
width: 1920,
|
484 |
+
height: 1080,
|
485 |
margin: 0.04,
|
486 |
minScale: 0.2,
|
487 |
maxScale: 2.0,
|
|
|
533 |
}, 200);
|
534 |
});
|
535 |
});
|
536 |
+
|
537 |
+
// Enhanced chart initialization
|
538 |
+
document.addEventListener('DOMContentLoaded', function() {
|
539 |
+
const ctx = document.getElementById('globalPrevalenceChart').getContext('2d');
|
540 |
+
new Chart(ctx, {
|
541 |
+
type: 'doughnut',
|
542 |
+
data: {
|
543 |
+
labels: ['Asia Pacific', 'Africa', 'Europe', 'Americas', 'Middle East'],
|
544 |
+
datasets: [{
|
545 |
+
data: [45, 20, 15, 15, 5],
|
546 |
+
backgroundColor: [
|
547 |
+
'#0984e3',
|
548 |
+
'#00b894',
|
549 |
+
'#6c5ce7',
|
550 |
+
'#fdcb6e',
|
551 |
+
'#e17055'
|
552 |
+
],
|
553 |
+
borderWidth: 2,
|
554 |
+
borderColor: 'white'
|
555 |
+
}]
|
556 |
+
},
|
557 |
+
options: {
|
558 |
+
responsive: true,
|
559 |
+
maintainAspectRatio: false,
|
560 |
+
plugins: {
|
561 |
+
legend: {
|
562 |
+
position: 'right',
|
563 |
+
labels: {
|
564 |
+
padding: 20,
|
565 |
+
font: {
|
566 |
+
size: 14
|
567 |
+
}
|
568 |
+
}
|
569 |
+
},
|
570 |
+
title: {
|
571 |
+
display: true,
|
572 |
+
text: 'Global Glaucoma Distribution (2023)',
|
573 |
+
font: {
|
574 |
+
size: 16,
|
575 |
+
weight: 'bold'
|
576 |
+
}
|
577 |
+
}
|
578 |
+
},
|
579 |
+
animation: {
|
580 |
+
animateScale: true,
|
581 |
+
animateRotate: true
|
582 |
+
}
|
583 |
+
}
|
584 |
+
});
|
585 |
+
});
|
586 |
</script>
|
587 |
</body>
|
588 |
</html>
|